acc,flat,kd,area,centers,PDBs,info
P26992,0.703,-10.0,2679.52,201,1UC6,Ciliary neurotrophic factor receptor subunit alpha (CNTF receptor subunit alpha) (CNTFR-alpha)
P26992,0.124,-5.0,865.892,135,1UC6,Ciliary neurotrophic factor receptor subunit alpha (CNTF receptor subunit alpha) (CNTFR-alpha)
P26992,0.699,-0.1,734.264,86,1UC6,Ciliary neurotrophic factor receptor subunit alpha (CNTF receptor subunit alpha) (CNTFR-alpha)
P15509,0.179,-39.8,3367.514,87,4NKQ;4RS1,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha (GM-CSF-R-alpha) (GMCSFR-alpha) (GMR-alpha) (CDw116) (CD antigen CD116)
P15509,0.113,59.8,2794.42,338,4NKQ;4RS1,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha (GM-CSF-R-alpha) (GMCSFR-alpha) (GMR-alpha) (CDw116) (CD antigen CD116)
Q99062,0.118,47.1,2244.744,636,2D9Q,Granulocyte colony-stimulating factor receptor (G-CSF receptor) (G-CSF-R) (CD antigen CD114)
Q99062,0.52,11.7,878.254,616,2D9Q,Granulocyte colony-stimulating factor receptor (G-CSF receptor) (G-CSF-R) (CD antigen CD114)
Q99062,0.109,-32.4,2295.85,507,2D9Q,Granulocyte colony-stimulating factor receptor (G-CSF receptor) (G-CSF-R) (CD antigen CD114)
Q99062,0.523,0.2,1328.246,409,2D9Q,Granulocyte colony-stimulating factor receptor (G-CSF receptor) (G-CSF-R) (CD antigen CD114)
Q99062,0.627,-0.5,1067.69,262,2D9Q,Granulocyte colony-stimulating factor receptor (G-CSF receptor) (G-CSF-R) (CD antigen CD114)
P19235,0.728,-4.0,1281.077,296,1CN4;1EBA;1EBP;1EER;1ERN;2JIX;2MV6;4Y5V;4Y5X;4Y5Y;6E2Q;6MOE;6MOF;6MOH;6MOI;6MOJ;6MOK;6MOL,Erythropoietin receptor (EPO-R)
P19235,0.055,41.9,4269.462,260,1CN4;1EBA;1EBP;1EER;1ERN;2JIX;2MV6;4Y5V;4Y5X;4Y5Y;6E2Q;6MOE;6MOF;6MOH;6MOI;6MOJ;6MOK;6MOL,Erythropoietin receptor (EPO-R)
P19235,0.03,-0.7,1651.276,153,1CN4;1EBA;1EBP;1EER;1ERN;2JIX;2MV6;4Y5V;4Y5X;4Y5Y;6E2Q;6MOE;6MOF;6MOH;6MOI;6MOJ;6MOK;6MOL,Erythropoietin receptor (EPO-R)
P19235,0.105,-20.0,1652.471,38,1CN4;1EBA;1EBP;1EER;1ERN;2JIX;2MV6;4Y5V;4Y5X;4Y5Y;6E2Q;6MOE;6MOF;6MOH;6MOI;6MOJ;6MOK;6MOL,Erythropoietin receptor (EPO-R)
P10912,0.036,-29.4,4101.83,213,1A22;1AXI;1HWG;1HWH;1KF9;2AEW;3HHR;5OEK;5OHD,Growth hormone receptor (GH receptor) (Somatotropin receptor) [Cleaved into: Growth hormone-binding protein (GH-binding protein) (GHBP) (Serum-binding protein)]
P10912,0.727,-15.4,461.357,59,1A22;1AXI;1HWG;1HWH;1KF9;2AEW;3HHR;5OEK;5OHD,Growth hormone receptor (GH receptor) (Somatotropin receptor) [Cleaved into: Growth hormone-binding protein (GH-binding protein) (GHBP) (Serum-binding protein)]
P10912,0.553,19.9,961.363,7,1A22;1AXI;1HWG;1HWH;1KF9;2AEW;3HHR;5OEK;5OHD,Growth hormone receptor (GH receptor) (Somatotropin receptor) [Cleaved into: Growth hormone-binding protein (GH-binding protein) (GHBP) (Serum-binding protein)]
P10912,0.15,58.9,2273.037,277,1A22;1AXI;1HWG;1HWH;1KF9;2AEW;3HHR;5OEK;5OHD,Growth hormone receptor (GH receptor) (Somatotropin receptor) [Cleaved into: Growth hormone-binding protein (GH-binding protein) (GHBP) (Serum-binding protein)]
Q14626,0.091,50.3,2825.168,379,6O4P,Interleukin-11 receptor subunit alpha (IL-11 receptor subunit alpha) (IL-11R subunit alpha) (IL-11R-alpha) (IL-11RA) [Cleaved into: Soluble interleukin-11 receptor subunit alpha (sIL-11R) (sIL-11RA) (sIL11RA)]
Q14626,0.126,-24.8,2380.585,144,6O4P,Interleukin-11 receptor subunit alpha (IL-11 receptor subunit alpha) (IL-11R subunit alpha) (IL-11R-alpha) (IL-11RA) [Cleaved into: Soluble interleukin-11 receptor subunit alpha (sIL-11R) (sIL-11RA) (sIL11RA)]
Q14626,0.042,-1.3,1630.638,254,6O4P,Interleukin-11 receptor subunit alpha (IL-11 receptor subunit alpha) (IL-11R subunit alpha) (IL-11R-alpha) (IL-11RA) [Cleaved into: Soluble interleukin-11 receptor subunit alpha (sIL-11R) (sIL-11RA) (sIL11RA)]
P42701,0.085,50.2,2662.549,561,6WDP;6WDQ,Interleukin-12 receptor subunit beta-1 (IL-12 receptor subunit beta-1) (IL-12R subunit beta-1) (IL-12R-beta-1) (IL-12RB1) (IL-12 receptor beta component) (CD antigen CD212)
P42701,0.184,11.0,2373.4,347,6WDP;6WDQ,Interleukin-12 receptor subunit beta-1 (IL-12 receptor subunit beta-1) (IL-12R subunit beta-1) (IL-12R-beta-1) (IL-12RB1) (IL-12 receptor beta component) (CD antigen CD212)
P42701,0.068,-10.0,1453.7,280,6WDP;6WDQ,Interleukin-12 receptor subunit beta-1 (IL-12 receptor subunit beta-1) (IL-12R subunit beta-1) (IL-12R-beta-1) (IL-12RB1) (IL-12 receptor beta component) (CD antigen CD212)
P42701,0.502,-7.8,625.914,107,6WDP;6WDQ,Interleukin-12 receptor subunit beta-1 (IL-12 receptor subunit beta-1) (IL-12R subunit beta-1) (IL-12R-beta-1) (IL-12RB1) (IL-12 receptor beta component) (CD antigen CD212)
Q99665,0.095,47.9,2540.024,637,,
Q99665,0.651,-0.3,2026.565,498,,
Q99665,0.116,-17.0,1646.258,411,,
Q99665,0.104,-1.3,1107.25,253,,
Q99665,0.232,32.6,1498.379,15,,
Q99665,0.104,-1.6,832.702,119,,
P78552,0.122,9.7,604.67,385,3BPN;3BPO;4HWB;5E4E,Interleukin-13 receptor subunit alpha-1 (IL-13 receptor subunit alpha-1) (IL-13R subunit alpha-1) (IL-13R-alpha-1) (IL-13RA1) (Cancer/testis antigen 19) (CT19) (CD antigen CD213a1)
P78552,0.071,78.4,2737.835,359,3BPN;3BPO;4HWB;5E4E,Interleukin-13 receptor subunit alpha-1 (IL-13 receptor subunit alpha-1) (IL-13R subunit alpha-1) (IL-13R-alpha-1) (IL-13RA1) (Cancer/testis antigen 19) (CT19) (CD antigen CD213a1)
P78552,0.688,-12.6,981.413,276,3BPN;3BPO;4HWB;5E4E,Interleukin-13 receptor subunit alpha-1 (IL-13 receptor subunit alpha-1) (IL-13R subunit alpha-1) (IL-13R-alpha-1) (IL-13RA1) (Cancer/testis antigen 19) (CT19) (CD antigen CD213a1)
P78552,0.631,-14.6,1318.02,89,3BPN;3BPO;4HWB;5E4E,Interleukin-13 receptor subunit alpha-1 (IL-13 receptor subunit alpha-1) (IL-13R subunit alpha-1) (IL-13R-alpha-1) (IL-13RA1) (Cancer/testis antigen 19) (CT19) (CD antigen CD213a1)
P78552,0.575,-19.6,1378.172,45,3BPN;3BPO;4HWB;5E4E,Interleukin-13 receptor subunit alpha-1 (IL-13 receptor subunit alpha-1) (IL-13R subunit alpha-1) (IL-13R-alpha-1) (IL-13RA1) (Cancer/testis antigen 19) (CT19) (CD antigen CD213a1)
Q14627,0.039,-5.4,1137.716,97,3LB6,Interleukin-13 receptor subunit alpha-2 (IL-13 receptor subunit alpha-2) (IL-13R subunit alpha-2) (IL-13R-alpha-2) (IL-13RA2) (Interleukin-13-binding protein) (CD antigen CD213a2)
Q14627,0.094,-22.5,2912.42,146,3LB6,Interleukin-13 receptor subunit alpha-2 (IL-13 receptor subunit alpha-2) (IL-13R subunit alpha-2) (IL-13R-alpha-2) (IL-13RA2) (Interleukin-13-binding protein) (CD antigen CD213a2)
Q14627,0.14,59.5,2357.249,352,3LB6,Interleukin-13 receptor subunit alpha-2 (IL-13 receptor subunit alpha-2) (IL-13R subunit alpha-2) (IL-13R-alpha-2) (IL-13RA2) (Interleukin-13-binding protein) (CD antigen CD213a2)
Q13261,0.538,-3.9,1048.157,58,2ERS;2Z3Q;2Z3R;4GS7,Interleukin-15 receptor subunit alpha (IL-15 receptor subunit alpha) (IL-15R-alpha) (IL-15RA) (CD antigen CD215) [Cleaved into: Soluble interleukin-15 receptor subunit alpha (sIL-15 receptor subunit alpha) (sIL-15R-alpha) (sIL-15RA)]
Q13261,0.167,54.1,3291.209,220,2ERS;2Z3Q;2Z3R;4GS7,Interleukin-15 receptor subunit alpha (IL-15 receptor subunit alpha) (IL-15R-alpha) (IL-15RA) (CD antigen CD215) [Cleaved into: Soluble interleukin-15 receptor subunit alpha (sIL-15 receptor subunit alpha) (sIL-15R-alpha) (sIL-15RA)]
O95256,0.09,49.4,6306.069,385,3WO4;6KN9;7FCH,Interleukin-18 receptor accessory protein (IL-18 receptor accessory protein) (IL-18RAcP) (EC 3.2.2.6) (Accessory protein-like) (AcPL) (CD218 antigen-like family member B) (CDw218b) (IL-1R accessory protein-like) (IL-1RAcPL) (Interleukin-1 receptor 7) (IL-1R-7) (IL-1R7) (Interleukin-18 receptor accessory protein-like) (Interleukin-18 receptor beta) (IL-18R-beta) (IL-18Rbeta) (CD antigen CD218b)
Q13478,0.077,12.1,2111.151,441,3WO3;3WO4;4R6U,Interleukin-18 receptor 1 (IL-18R-1) (IL-18R1) (EC 3.2.2.6) (CD218 antigen-like family member A) (CDw218a) (IL1 receptor-related protein) (IL-1Rrp) (IL1R-rp) (Interleukin-18 receptor alpha) (IL-18R-alpha) (IL-18Ralpha) (CD antigen CD218a)
Q13478,0.061,59.5,5224.391,348,3WO3;3WO4;4R6U,Interleukin-18 receptor 1 (IL-18R-1) (IL-18R1) (EC 3.2.2.6) (CD218 antigen-like family member A) (CDw218a) (IL1 receptor-related protein) (IL-1Rrp) (IL1R-rp) (Interleukin-18 receptor alpha) (IL-18R-alpha) (IL-18Ralpha) (CD antigen CD218a)
Q13478,0.683,0.6,1975.587,238,3WO3;3WO4;4R6U,Interleukin-18 receptor 1 (IL-18R-1) (IL-18R1) (EC 3.2.2.6) (CD218 antigen-like family member A) (CDw218a) (IL1 receptor-related protein) (IL-1Rrp) (IL1R-rp) (Interleukin-18 receptor alpha) (IL-18R-alpha) (IL-18Ralpha) (CD antigen CD218a)
Q9NPH3,0.028,4.9,3532.923,307,3O4O;4DEP;7FCC,Interleukin-1 receptor accessory protein (IL-1 receptor accessory protein) (IL-1RAcP) (EC 3.2.2.6) (Interleukin-1 receptor 3) (IL-1R-3) (IL-1R3)
Q9NPH3,0.067,57.0,5407.791,382,3O4O;4DEP;7FCC,Interleukin-1 receptor accessory protein (IL-1 receptor accessory protein) (IL-1RAcP) (EC 3.2.2.6) (Interleukin-1 receptor 3) (IL-1R-3) (IL-1R3)
P14778,0.191,34.8,1506.927,8,1G0Y;1IRA;1ITB;4DEP;4GAF,"Interleukin-1 receptor type 1 (IL-1R-1) (IL-1RT-1) (IL-1RT1) (EC 3.2.2.6) (CD121 antigen-like family member A) (Interleukin-1 receptor alpha) (IL-1R-alpha) (Interleukin-1 receptor type I) (p80) (CD antigen CD121a) [Cleaved into: Interleukin-1 receptor type 1, membrane form (mIL-1R1) (mIL-1RI); Interleukin-1 receptor type 1, soluble form (sIL-1R1) (sIL-1RI)]"
P14778,0.704,6.3,2020.955,143,1G0Y;1IRA;1ITB;4DEP;4GAF,"Interleukin-1 receptor type 1 (IL-1R-1) (IL-1RT-1) (IL-1RT1) (EC 3.2.2.6) (CD121 antigen-like family member A) (Interleukin-1 receptor alpha) (IL-1R-alpha) (Interleukin-1 receptor type I) (p80) (CD antigen CD121a) [Cleaved into: Interleukin-1 receptor type 1, membrane form (mIL-1R1) (mIL-1RI); Interleukin-1 receptor type 1, soluble form (sIL-1R1) (sIL-1RI)]"
P14778,0.687,6.1,1117.331,258,1G0Y;1IRA;1ITB;4DEP;4GAF,"Interleukin-1 receptor type 1 (IL-1R-1) (IL-1RT-1) (IL-1RT1) (EC 3.2.2.6) (CD121 antigen-like family member A) (Interleukin-1 receptor alpha) (IL-1R-alpha) (Interleukin-1 receptor type I) (p80) (CD antigen CD121a) [Cleaved into: Interleukin-1 receptor type 1, membrane form (mIL-1R1) (mIL-1RI); Interleukin-1 receptor type 1, soluble form (sIL-1R1) (sIL-1RI)]"
P14778,0.734,-2.2,1436.442,247,1G0Y;1IRA;1ITB;4DEP;4GAF,"Interleukin-1 receptor type 1 (IL-1R-1) (IL-1RT-1) (IL-1RT1) (EC 3.2.2.6) (CD121 antigen-like family member A) (Interleukin-1 receptor alpha) (IL-1R-alpha) (Interleukin-1 receptor type I) (p80) (CD antigen CD121a) [Cleaved into: Interleukin-1 receptor type 1, membrane form (mIL-1R1) (mIL-1RI); Interleukin-1 receptor type 1, soluble form (sIL-1R1) (sIL-1RI)]"
P14778,0.038,30.7,4859.927,345,1G0Y;1IRA;1ITB;4DEP;4GAF,"Interleukin-1 receptor type 1 (IL-1R-1) (IL-1RT-1) (IL-1RT1) (EC 3.2.2.6) (CD121 antigen-like family member A) (Interleukin-1 receptor alpha) (IL-1R-alpha) (Interleukin-1 receptor type I) (p80) (CD antigen CD121a) [Cleaved into: Interleukin-1 receptor type 1, membrane form (mIL-1R1) (mIL-1RI); Interleukin-1 receptor type 1, soluble form (sIL-1R1) (sIL-1RI)]"
P14778,0.107,-14.6,2317.811,503,1G0Y;1IRA;1ITB;4DEP;4GAF,"Interleukin-1 receptor type 1 (IL-1R-1) (IL-1RT-1) (IL-1RT1) (EC 3.2.2.6) (CD121 antigen-like family member A) (Interleukin-1 receptor alpha) (IL-1R-alpha) (Interleukin-1 receptor type I) (p80) (CD antigen CD121a) [Cleaved into: Interleukin-1 receptor type 1, membrane form (mIL-1R1) (mIL-1RI); Interleukin-1 receptor type 1, soluble form (sIL-1R1) (sIL-1RI)]"
P27930,0.645,-27.3,3615.24,154,3O4O,"Interleukin-1 receptor type 2 (IL-1R-2) (IL-1RT-2) (IL-1RT2) (CD121 antigen-like family member B) (CDw121b) (IL-1 type II receptor) (Interleukin-1 receptor beta) (IL-1R-beta) (Interleukin-1 receptor type II) (CD antigen CD121b) [Cleaved into: Interleukin-1 receptor type 2, membrane form (mIL-1R2) (mIL-1RII); Interleukin-1 receptor type 2, soluble form (sIL-1R2) (sIL-1RII)]"
P27930,0.068,9.2,1839.568,241,3O4O,"Interleukin-1 receptor type 2 (IL-1R-2) (IL-1RT-2) (IL-1RT2) (CD121 antigen-like family member B) (CDw121b) (IL-1 type II receptor) (Interleukin-1 receptor beta) (IL-1R-beta) (Interleukin-1 receptor type II) (CD antigen CD121b) [Cleaved into: Interleukin-1 receptor type 2, membrane form (mIL-1R2) (mIL-1RII); Interleukin-1 receptor type 2, soluble form (sIL-1R2) (sIL-1RII)]"
P27930,0.166,29.6,2231.6,362,3O4O,"Interleukin-1 receptor type 2 (IL-1R-2) (IL-1RT-2) (IL-1RT2) (CD121 antigen-like family member B) (CDw121b) (IL-1 type II receptor) (Interleukin-1 receptor beta) (IL-1R-beta) (Interleukin-1 receptor type II) (CD antigen CD121b) [Cleaved into: Interleukin-1 receptor type 2, membrane form (mIL-1R2) (mIL-1RII); Interleukin-1 receptor type 2, soluble form (sIL-1R2) (sIL-1RII)]"
Q9HBE5,0.656,3.2,1002.105,280,3TGX;4NZD;6PLH;7KQ7,Interleukin-21 receptor (IL-21 receptor) (IL-21R) (Novel interleukin receptor) (CD antigen CD360)
Q9HBE5,0.201,53.6,1535.431,245,3TGX;4NZD;6PLH;7KQ7,Interleukin-21 receptor (IL-21 receptor) (IL-21R) (Novel interleukin receptor) (CD antigen CD360)
Q9HBE5,0.117,-28.7,2332.569,34,3TGX;4NZD;6PLH;7KQ7,Interleukin-21 receptor (IL-21 receptor) (IL-21R) (Novel interleukin receptor) (CD antigen CD360)
Q5VWK5,0.023,62.2,3682.175,373,5MZV;6WDQ,Interleukin-23 receptor (IL-23 receptor) (IL-23R)
Q5VWK5,0.038,-65.7,3954.261,177,5MZV;6WDQ,Interleukin-23 receptor (IL-23 receptor) (IL-23R)
Q5VWK5,0.487,-4.0,870.947,135,5MZV;6WDQ,Interleukin-23 receptor (IL-23 receptor) (IL-23R)
Q5VWK5,0.221,19.0,1649.872,11,5MZV;6WDQ,Interleukin-23 receptor (IL-23 receptor) (IL-23R)
Q5VWK5,0.172,-16.1,1998.035,100,5MZV;6WDQ,Interleukin-23 receptor (IL-23 receptor) (IL-23R)
P01589,0.621,-11.2,1712.508,149,1Z92;2B5I;2ERJ;3IU3;3NFP;6VWU;6YIO;7F9W,Interleukin-2 receptor subunit alpha (IL-2 receptor subunit alpha) (IL-2-RA) (IL-2R subunit alpha) (IL2-RA) (TAC antigen) (p55) (CD antigen CD25)
P01589,0.111,-14.3,1599.954,140,1Z92;2B5I;2ERJ;3IU3;3NFP;6VWU;6YIO;7F9W,Interleukin-2 receptor subunit alpha (IL-2 receptor subunit alpha) (IL-2-RA) (IL-2R subunit alpha) (IL2-RA) (TAC antigen) (p55) (CD antigen CD25)
P01589,0.134,36.2,2369.208,251,1Z92;2B5I;2ERJ;3IU3;3NFP;6VWU;6YIO;7F9W,Interleukin-2 receptor subunit alpha (IL-2 receptor subunit alpha) (IL-2-RA) (IL-2R subunit alpha) (IL2-RA) (TAC antigen) (p55) (CD antigen CD25)
P14784,0.044,5.9,1103.179,292,2B5I;2ERJ;3QAZ;4GS7;5M5E;6E8K;7S2S,Interleukin-2 receptor subunit beta (IL-2 receptor subunit beta) (IL-2R subunit beta) (IL-2RB) (High affinity IL-2 receptor subunit beta) (Interleukin-15 receptor subunit beta) (p70-75) (p75) (CD antigen CD122)
P14784,0.065,48.8,2786.771,259,2B5I;2ERJ;3QAZ;4GS7;5M5E;6E8K;7S2S,Interleukin-2 receptor subunit beta (IL-2 receptor subunit beta) (IL-2R subunit beta) (IL-2RB) (High affinity IL-2 receptor subunit beta) (Interleukin-15 receptor subunit beta) (p70-75) (p75) (CD antigen CD122)
P14784,0.652,2.3,1045.509,184,2B5I;2ERJ;3QAZ;4GS7;5M5E;6E8K;7S2S,Interleukin-2 receptor subunit beta (IL-2 receptor subunit beta) (IL-2R subunit beta) (IL-2RB) (High affinity IL-2 receptor subunit beta) (Interleukin-15 receptor subunit beta) (p70-75) (p75) (CD antigen CD122)
P14784,0.137,-11.4,3571.356,36,2B5I;2ERJ;3QAZ;4GS7;5M5E;6E8K;7S2S,Interleukin-2 receptor subunit beta (IL-2 receptor subunit beta) (IL-2R subunit beta) (IL-2RB) (High affinity IL-2 receptor subunit beta) (Interleukin-15 receptor subunit beta) (p70-75) (p75) (CD antigen CD122)
P31785,0.08,17.1,1400.868,308,2B5I;2ERJ;3BPL;3QAZ;3QB7;4GS7;5M5E;6OEL;7S2R,Cytokine receptor common subunit gamma (Interleukin-2 receptor subunit gamma) (IL-2 receptor subunit gamma) (IL-2R subunit gamma) (IL-2RG) (gammaC) (p64) (CD antigen CD132)
P31785,0.11,53.0,2442.429,271,2B5I;2ERJ;3BPL;3QAZ;3QB7;4GS7;5M5E;6OEL;7S2R,Cytokine receptor common subunit gamma (Interleukin-2 receptor subunit gamma) (IL-2 receptor subunit gamma) (IL-2R subunit gamma) (IL-2RG) (gammaC) (p64) (CD antigen CD132)
P31785,0.664,-19.5,1787.56,179,2B5I;2ERJ;3BPL;3QAZ;3QB7;4GS7;5M5E;6OEL;7S2R,Cytokine receptor common subunit gamma (Interleukin-2 receptor subunit gamma) (IL-2 receptor subunit gamma) (IL-2R subunit gamma) (IL-2RG) (gammaC) (p64) (CD antigen CD132)
P31785,0.587,-27.5,2309.202,63,2B5I;2ERJ;3BPL;3QAZ;3QB7;4GS7;5M5E;6OEL;7S2R,Cytokine receptor common subunit gamma (Interleukin-2 receptor subunit gamma) (IL-2 receptor subunit gamma) (IL-2R subunit gamma) (IL-2RG) (gammaC) (p64) (CD antigen CD132)
Q8NI17,0.056,63.1,3352.345,524,,
Q8NI17,0.736,-1.3,1028.747,235,,
Q8NI17,0.049,-14.4,3771.014,229,,
Q8NI17,0.617,-7.1,936.384,94,,
P26951,0.089,54.0,3148.771,318,4JZJ;5UV8;5UWC;6NMY,Interleukin-3 receptor subunit alpha (IL-3 receptor subunit alpha) (IL-3R subunit alpha) (IL-3R-alpha) (IL-3RA) (CD antigen CD123)
P26951,0.1,-36.4,3732.69,198,4JZJ;5UV8;5UWC;6NMY,Interleukin-3 receptor subunit alpha (IL-3 receptor subunit alpha) (IL-3R subunit alpha) (IL-3R-alpha) (IL-3RA) (CD antigen CD123)
P32927,0.061,-19.2,5444.143,120,1C8P;1EGJ;1GH7;2GYS;2NA8;2NA9;4NKQ;5DWU,Cytokine receptor common subunit beta (CDw131) (GM-CSF/IL-3/IL-5 receptor common beta subunit) (CD antigen CD131)
P32927,0.593,-4.0,1653.133,321,1C8P;1EGJ;1GH7;2GYS;2NA8;2NA9;4NKQ;5DWU,Cytokine receptor common subunit beta (CDw131) (GM-CSF/IL-3/IL-5 receptor common beta subunit) (CD antigen CD131)
P32927,0.076,-21.6,2122.014,334,1C8P;1EGJ;1GH7;2GYS;2NA8;2NA9;4NKQ;5DWU,Cytokine receptor common subunit beta (CDw131) (GM-CSF/IL-3/IL-5 receptor common beta subunit) (CD antigen CD131)
P32927,0.063,47.9,4275.892,456,1C8P;1EGJ;1GH7;2GYS;2NA8;2NA9;4NKQ;5DWU,Cytokine receptor common subunit beta (CDw131) (GM-CSF/IL-3/IL-5 receptor common beta subunit) (CD antigen CD131)
P24394,0.135,-17.6,3033.922,36,1IAR;1IRS;3BPL;3BPN;3BPO;5E4E;6OEL;6WGL,Interleukin-4 receptor subunit alpha (IL-4 receptor subunit alpha) (IL-4R subunit alpha) (IL-4R-alpha) (IL-4RA) (CD antigen CD124) [Cleaved into: Soluble interleukin-4 receptor subunit alpha (Soluble IL-4 receptor subunit alpha) (Soluble IL-4R-alpha) (sIL4Ralpha/prot) (IL-4-binding protein) (IL4-BP)]
P24394,0.595,-12.8,1305.793,175,1IAR;1IRS;3BPL;3BPN;3BPO;5E4E;6OEL;6WGL,Interleukin-4 receptor subunit alpha (IL-4 receptor subunit alpha) (IL-4R subunit alpha) (IL-4R-alpha) (IL-4RA) (CD antigen CD124) [Cleaved into: Soluble interleukin-4 receptor subunit alpha (Soluble IL-4 receptor subunit alpha) (Soluble IL-4R-alpha) (sIL4Ralpha/prot) (IL-4-binding protein) (IL4-BP)]
P24394,0.061,57.5,2715.71,244,1IAR;1IRS;3BPL;3BPN;3BPO;5E4E;6OEL;6WGL,Interleukin-4 receptor subunit alpha (IL-4 receptor subunit alpha) (IL-4R subunit alpha) (IL-4R-alpha) (IL-4RA) (CD antigen CD124) [Cleaved into: Soluble interleukin-4 receptor subunit alpha (Soluble IL-4 receptor subunit alpha) (Soluble IL-4R-alpha) (sIL4Ralpha/prot) (IL-4-binding protein) (IL4-BP)]
P24394,0.615,12.1,803.202,403,1IAR;1IRS;3BPL;3BPN;3BPO;5E4E;6OEL;6WGL,Interleukin-4 receptor subunit alpha (IL-4 receptor subunit alpha) (IL-4R subunit alpha) (IL-4R-alpha) (IL-4RA) (CD antigen CD124) [Cleaved into: Soluble interleukin-4 receptor subunit alpha (Soluble IL-4 receptor subunit alpha) (Soluble IL-4R-alpha) (sIL4Ralpha/prot) (IL-4-binding protein) (IL4-BP)]
Q01344,0.107,-36.4,4572.368,175,1OBX;1OBZ;3QT2;3VA2;6H41,Interleukin-5 receptor subunit alpha (IL-5 receptor subunit alpha) (IL-5R subunit alpha) (IL-5R-alpha) (IL-5RA) (CDw125) (CD antigen CD125)
Q01344,0.06,84.3,2820.756,356,1OBX;1OBZ;3QT2;3VA2;6H41,Interleukin-5 receptor subunit alpha (IL-5 receptor subunit alpha) (IL-5R subunit alpha) (IL-5R-alpha) (IL-5RA) (CDw125) (CD antigen CD125)
P08887,0.16,28.9,1883.77,381,1N26;1P9M;2ARW;5FUC;7DC8,Interleukin-6 receptor subunit alpha (IL-6 receptor subunit alpha) (IL-6R subunit alpha) (IL-6R-alpha) (IL-6RA) (IL-6R 1) (Membrane glycoprotein 80) (gp80) (CD antigen CD126) [Cleaved into: Soluble interleukin-6 receptor subunit alpha (sIL6R)]
P08887,0.043,-24.0,2423.563,151,1N26;1P9M;2ARW;5FUC;7DC8,Interleukin-6 receptor subunit alpha (IL-6 receptor subunit alpha) (IL-6R subunit alpha) (IL-6R-alpha) (IL-6RA) (IL-6R 1) (Membrane glycoprotein 80) (gp80) (CD antigen CD126) [Cleaved into: Soluble interleukin-6 receptor subunit alpha (sIL6R)]
P08887,0.129,-24.5,2313.323,111,1N26;1P9M;2ARW;5FUC;7DC8,Interleukin-6 receptor subunit alpha (IL-6 receptor subunit alpha) (IL-6R subunit alpha) (IL-6R-alpha) (IL-6RA) (IL-6R 1) (Membrane glycoprotein 80) (gp80) (CD antigen CD126) [Cleaved into: Soluble interleukin-6 receptor subunit alpha (sIL6R)]
P08887,0.64,-0.3,1501.46,36,1N26;1P9M;2ARW;5FUC;7DC8,Interleukin-6 receptor subunit alpha (IL-6 receptor subunit alpha) (IL-6R subunit alpha) (IL-6R-alpha) (IL-6RA) (IL-6R 1) (Membrane glycoprotein 80) (gp80) (CD antigen CD126) [Cleaved into: Soluble interleukin-6 receptor subunit alpha (sIL6R)]
P40189,0.081,54.2,2454.856,629,1BJ8;1BQU;1I1R;1P9M;1PVH;3L5H;3L5I;3L5J;7U7N,Interleukin-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (CDw130) (Interleukin-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130)
P40189,0.573,-25.9,6902.099,331,1BJ8;1BQU;1I1R;1P9M;1PVH;3L5H;3L5I;3L5J;7U7N,Interleukin-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (CDw130) (Interleukin-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130)
P40189,0.672,11.9,626.575,587,1BJ8;1BQU;1I1R;1P9M;1PVH;3L5H;3L5I;3L5J;7U7N,Interleukin-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (CDw130) (Interleukin-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130)
P40189,0.674,12.5,760.858,189,1BJ8;1BQU;1I1R;1P9M;1PVH;3L5H;3L5I;3L5J;7U7N,Interleukin-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (CDw130) (Interleukin-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130)
P40189,0.11,0.0,811.216,107,1BJ8;1BQU;1I1R;1P9M;1PVH;3L5H;3L5I;3L5J;7U7N,Interleukin-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (CDw130) (Interleukin-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130)
P40189,0.661,5.6,478.537,47,1BJ8;1BQU;1I1R;1P9M;1PVH;3L5H;3L5I;3L5J;7U7N,Interleukin-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (CDw130) (Interleukin-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130)
P16871,0.081,66.6,2870.292,256,3DI2;3DI3;3UP1;5J11;6P50;6P67;7OPB,Interleukin-7 receptor subunit alpha (IL-7 receptor subunit alpha) (IL-7R subunit alpha) (IL-7R-alpha) (IL-7RA) (CDw127) (CD antigen CD127)
P16871,0.2,-17.7,3880.32,45,3DI2;3DI3;3UP1;5J11;6P50;6P67;7OPB,Interleukin-7 receptor subunit alpha (IL-7 receptor subunit alpha) (IL-7R subunit alpha) (IL-7R-alpha) (IL-7RA) (CDw127) (CD antigen CD127)
Q01113,0.671,10.9,1075.022,312,,
Q01113,0.204,40.7,1962.376,281,,
Q01113,0.726,-0.4,3266.383,172,,
Q01638,0.06,58.3,5005.557,350,4KC3,Interleukin-1 receptor-like 1 (EC 3.2.2.6) (Protein ST2)
Q01638,0.153,11.7,2904.96,212,4KC3,Interleukin-1 receptor-like 1 (EC 3.2.2.6) (Protein ST2)
Q01638,0.16,3.4,768.871,113,4KC3,Interleukin-1 receptor-like 1 (EC 3.2.2.6) (Protein ST2)
Q9HB29,0.046,55.8,4475.344,341,6U6U,Interleukin-1 receptor-like 2 (EC 3.2.2.6) (IL-36 receptor) (IL-36R) (Interleukin-1 receptor-related protein 2) (IL-1Rrp2) (IL1R-rp2)
Q9HB29,0.083,-0.9,1062.066,472,6U6U,Interleukin-1 receptor-like 2 (EC 3.2.2.6) (IL-36 receptor) (IL-36R) (Interleukin-1 receptor-related protein 2) (IL-1Rrp2) (IL1R-rp2)
Q9HB29,0.64,-6.5,2091.371,248,6U6U,Interleukin-1 receptor-like 2 (EC 3.2.2.6) (IL-36 receptor) (IL-36R) (Interleukin-1 receptor-related protein 2) (IL-1Rrp2) (IL1R-rp2)
Q9HB29,0.059,-7.1,2090.01,109,6U6U,Interleukin-1 receptor-like 2 (EC 3.2.2.6) (IL-36 receptor) (IL-36R) (Interleukin-1 receptor-related protein 2) (IL-1Rrp2) (IL1R-rp2)
Q9NZN1,0.621,-13.7,1876.499,489,1T3G;4M92;5WY8,Interleukin-1 receptor accessory protein-like 1 (IL-1-RAPL-1) (IL-1RAPL-1) (IL1RAPL-1) (EC 3.2.2.6) (Oligophrenin-4) (Three immunoglobulin domain-containing IL-1 receptor-related 2) (TIGIRR-2) (X-linked interleukin-1 receptor accessory protein-like 1)
Q9NZN1,0.058,40.4,3899.44,370,1T3G;4M92;5WY8,Interleukin-1 receptor accessory protein-like 1 (IL-1-RAPL-1) (IL-1RAPL-1) (IL1RAPL-1) (EC 3.2.2.6) (Oligophrenin-4) (Three immunoglobulin domain-containing IL-1 receptor-related 2) (TIGIRR-2) (X-linked interleukin-1 receptor accessory protein-like 1)
Q9NZN1,0.621,-9.4,1222.335,267,1T3G;4M92;5WY8,Interleukin-1 receptor accessory protein-like 1 (IL-1-RAPL-1) (IL-1RAPL-1) (IL1RAPL-1) (EC 3.2.2.6) (Oligophrenin-4) (Three immunoglobulin domain-containing IL-1 receptor-related 2) (TIGIRR-2) (X-linked interleukin-1 receptor accessory protein-like 1)
Q9NZN1,0.677,5.8,780.196,280,1T3G;4M92;5WY8,Interleukin-1 receptor accessory protein-like 1 (IL-1-RAPL-1) (IL-1RAPL-1) (IL1RAPL-1) (EC 3.2.2.6) (Oligophrenin-4) (Three immunoglobulin domain-containing IL-1 receptor-related 2) (TIGIRR-2) (X-linked interleukin-1 receptor accessory protein-like 1)
Q9NP60,0.109,-10.0,1630.67,486,7FD3;7SZL,X-linked interleukin-1 receptor accessory protein-like 2 (IL-1 receptor accessory protein-like 2) (IL-1-RAPL-2) (IL-1RAPL-2) (IL1RAPL-2) (EC 3.2.2.6) (IL1RAPL-2-related protein) (Interleukin-1 receptor 9) (IL-1R-9) (IL-1R9) (Three immunoglobulin domain-containing IL-1 receptor-related 1) (TIGIRR-1)
Q9NP60,0.04,35.9,6713.944,368,7FD3;7SZL,X-linked interleukin-1 receptor accessory protein-like 2 (IL-1 receptor accessory protein-like 2) (IL-1-RAPL-2) (IL-1RAPL-2) (IL1RAPL-2) (EC 3.2.2.6) (IL1RAPL-2-related protein) (Interleukin-1 receptor 9) (IL-1R-9) (IL-1R9) (Three immunoglobulin domain-containing IL-1 receptor-related 1) (TIGIRR-1)
Q9NP60,0.074,-4.4,1722.241,125,7FD3;7SZL,X-linked interleukin-1 receptor accessory protein-like 2 (IL-1 receptor accessory protein-like 2) (IL-1-RAPL-2) (IL-1RAPL-2) (IL1RAPL-2) (EC 3.2.2.6) (IL1RAPL-2-related protein) (Interleukin-1 receptor 9) (IL-1R-9) (IL-1R9) (Three immunoglobulin domain-containing IL-1 receptor-related 1) (TIGIRR-1)
Q9NP60,0.625,-1.1,959.458,77,7FD3;7SZL,X-linked interleukin-1 receptor accessory protein-like 2 (IL-1 receptor accessory protein-like 2) (IL-1-RAPL-2) (IL-1RAPL-2) (IL1RAPL-2) (EC 3.2.2.6) (IL1RAPL-2-related protein) (Interleukin-1 receptor 9) (IL-1R-9) (IL-1R9) (Three immunoglobulin domain-containing IL-1 receptor-related 1) (TIGIRR-1)
P48357,0.712,35.2,1650.918,853,3V6O;6E2P,Leptin receptor (LEP-R) (HuB219) (OB receptor) (OB-R) (CD antigen CD295)
P48357,0.037,-7.4,2068.62,787,3V6O;6E2P,Leptin receptor (LEP-R) (HuB219) (OB receptor) (OB-R) (CD antigen CD295)
P48357,0.618,3.0,935.534,884,3V6O;6E2P,Leptin receptor (LEP-R) (HuB219) (OB receptor) (OB-R) (CD antigen CD295)
P48357,0.659,13.2,990.705,630,3V6O;6E2P,Leptin receptor (LEP-R) (HuB219) (OB receptor) (OB-R) (CD antigen CD295)
P48357,0.126,21.0,2812.394,530,3V6O;6E2P,Leptin receptor (LEP-R) (HuB219) (OB receptor) (OB-R) (CD antigen CD295)
P48357,0.088,-7.2,2154.054,229,3V6O;6E2P,Leptin receptor (LEP-R) (HuB219) (OB receptor) (OB-R) (CD antigen CD295)
P42702,0.079,59.7,2795.267,849,3E0G,Leukemia inhibitory factor receptor (LIF receptor) (LIF-R) (CD antigen CD118)
P42702,0.04,-11.7,2108.822,698,3E0G,Leukemia inhibitory factor receptor (LIF receptor) (LIF-R) (CD antigen CD118)
P42702,0.025,-4.6,1905.318,815,3E0G,Leukemia inhibitory factor receptor (LIF receptor) (LIF-R) (CD antigen CD118)
P42702,0.027,0.9,1758.192,173,3E0G,Leukemia inhibitory factor receptor (LIF receptor) (LIF-R) (CD antigen CD118)
Q99650,0.094,-41.8,2282.978,230,,
Q99650,0.087,12.2,1002.36,11,,
Q99650,0.015,-13.0,1308.605,412,,
Q99650,0.702,22.4,2855.638,518,,
Q99650,0.647,-2.8,920.415,731,,
Q99650,0.094,49.8,2446.216,751,,
P16471,0.137,59.5,2317.775,246,1BP3;2LFG;2N7I;3D48;3MZG;3N06;3N0P;3NCB;3NCC;3NCE;3NCF;4I18,Prolactin receptor (PRL-R)
P16471,0.129,-47.8,3624.41,37,1BP3;2LFG;2N7I;3D48;3MZG;3N06;3N0P;3NCB;3NCC;3NCE;3NCF;4I18,Prolactin receptor (PRL-R)
P16471,0.211,27.9,1338.135,12,1BP3;2LFG;2N7I;3D48;3MZG;3N06;3N0P;3NCB;3NCC;3NCE;3NCF;4I18,Prolactin receptor (PRL-R)
Q6IA17,0.769,6.4,1385.041,31,,
Q6IA17,0.052,35.8,4987.474,143,,
P40238,0.517,4.9,926.492,542,,
P40238,0.059,37.5,3743.447,506,,
P40238,0.678,-19.0,3280.513,142,,
Q13651,0.114,66.0,2619.792,247,1J7V;1LQS;1Y6K;1Y6M;1Y6N;5IXI;6X93,Interleukin-10 receptor subunit alpha (IL-10 receptor subunit alpha) (IL-10R subunit alpha) (IL-10RA) (CDw210a) (Interleukin-10 receptor subunit 1) (IL-10R subunit 1) (IL-10R1) (CD antigen CD210)
Q13651,0.137,-2.2,915.062,192,1J7V;1LQS;1Y6K;1Y6M;1Y6N;5IXI;6X93,Interleukin-10 receptor subunit alpha (IL-10 receptor subunit alpha) (IL-10R subunit alpha) (IL-10RA) (CDw210a) (Interleukin-10 receptor subunit 1) (IL-10R subunit 1) (IL-10R1) (CD antigen CD210)
Q13651,0.071,-5.7,826.921,204,1J7V;1LQS;1Y6K;1Y6M;1Y6N;5IXI;6X93,Interleukin-10 receptor subunit alpha (IL-10 receptor subunit alpha) (IL-10R subunit alpha) (IL-10RA) (CDw210a) (Interleukin-10 receptor subunit 1) (IL-10R subunit 1) (IL-10R1) (CD antigen CD210)
Q13651,0.134,32.8,1396.437,9,1J7V;1LQS;1Y6K;1Y6M;1Y6N;5IXI;6X93,Interleukin-10 receptor subunit alpha (IL-10 receptor subunit alpha) (IL-10R subunit alpha) (IL-10RA) (CDw210a) (Interleukin-10 receptor subunit 1) (IL-10R subunit 1) (IL-10R1) (CD antigen CD210)
Q08334,0.043,63.0,3178.681,233,3LQM;5T5W;6X93,Interleukin-10 receptor subunit beta (IL-10 receptor subunit beta) (IL-10R subunit beta) (IL-10RB) (Cytokine receptor class-II member 4) (Cytokine receptor family 2 member 4) (CRF2-4) (Interleukin-10 receptor subunit 2) (IL-10R subunit 2) (IL-10R2) (CD antigen CDw210b)
Q08334,0.075,-33.2,2972.755,116,3LQM;5T5W;6X93,Interleukin-10 receptor subunit beta (IL-10 receptor subunit beta) (IL-10R subunit beta) (IL-10RB) (Cytokine receptor class-II member 4) (Cytokine receptor family 2 member 4) (CRF2-4) (Interleukin-10 receptor subunit 2) (IL-10R subunit 2) (IL-10R2) (CD antigen CDw210b)
Q08334,0.603,-34.0,1710.346,79,3LQM;5T5W;6X93,Interleukin-10 receptor subunit beta (IL-10 receptor subunit beta) (IL-10R subunit beta) (IL-10RB) (Cytokine receptor class-II member 4) (Cytokine receptor family 2 member 4) (CRF2-4) (Interleukin-10 receptor subunit 2) (IL-10R subunit 2) (IL-10R2) (CD antigen CDw210b)
Q9UHF4,0.071,42.7,3207.417,263,4DOH,Interleukin-20 receptor subunit alpha (IL-20 receptor subunit alpha) (IL-20R-alpha) (IL-20RA) (Cytokine receptor class-II member 8) (Cytokine receptor family 2 member 8) (CRF2-8) (IL-20R1) (ZcytoR7)
Q9UHF4,0.477,-4.5,1131.639,205,4DOH,Interleukin-20 receptor subunit alpha (IL-20 receptor subunit alpha) (IL-20R-alpha) (IL-20RA) (Cytokine receptor class-II member 8) (Cytokine receptor family 2 member 8) (CRF2-8) (IL-20R1) (ZcytoR7)
Q9UHF4,0.122,-33.9,2364.509,135,4DOH,Interleukin-20 receptor subunit alpha (IL-20 receptor subunit alpha) (IL-20R-alpha) (IL-20RA) (Cytokine receptor class-II member 8) (Cytokine receptor family 2 member 8) (CRF2-8) (IL-20R1) (ZcytoR7)
Q6UXL0,0.133,33.1,2098.137,15,4DOH;6DF3,Interleukin-20 receptor subunit beta (IL-20 receptor subunit beta) (IL-20R-beta) (IL-20RB) (Fibronectin type III domain containing 6) (FNDC6) (IL-20R2)
Q6UXL0,0.582,-16.9,1732.166,45,4DOH;6DF3,Interleukin-20 receptor subunit beta (IL-20 receptor subunit beta) (IL-20R-beta) (IL-20RB) (Fibronectin type III domain containing 6) (FNDC6) (IL-20R2)
Q6UXL0,0.545,0.5,861.473,72,4DOH;6DF3,Interleukin-20 receptor subunit beta (IL-20 receptor subunit beta) (IL-20R-beta) (IL-20RB) (Fibronectin type III domain containing 6) (FNDC6) (IL-20R2)
Q6UXL0,0.073,74.5,2961.606,242,4DOH;6DF3,Interleukin-20 receptor subunit beta (IL-20 receptor subunit beta) (IL-20R-beta) (IL-20RB) (Fibronectin type III domain containing 6) (FNDC6) (IL-20R2)
Q8N6P7,0.043,15.1,4780.856,227,3DGC;3DLQ;6DF3,Interleukin-22 receptor subunit alpha-1 (IL-22 receptor subunit alpha-1) (IL-22R-alpha-1) (IL-22RA1) (Cytokine receptor class-II member 9) (Cytokine receptor family 2 member 9) (CRF2-9) (ZcytoR11)
P17181,0.056,62.0,3677.215,453,3S98;3SE3;3SE4;4PO6,Interferon alpha/beta receptor 1 (IFN-R-1) (IFN-alpha/beta receptor 1) (Cytokine receptor class-II member 1) (Cytokine receptor family 2 member 1) (CRF2-1) (Type I interferon receptor 1)
P17181,0.101,-23.2,5630.335,265,3S98;3SE3;3SE4;4PO6,Interferon alpha/beta receptor 1 (IFN-R-1) (IFN-alpha/beta receptor 1) (Cytokine receptor class-II member 1) (Cytokine receptor family 2 member 1) (CRF2-1) (Type I interferon receptor 1)
P17181,0.645,-7.1,840.654,130,3S98;3SE3;3SE4;4PO6,Interferon alpha/beta receptor 1 (IFN-R-1) (IFN-alpha/beta receptor 1) (Cytokine receptor class-II member 1) (Cytokine receptor family 2 member 1) (CRF2-1) (Type I interferon receptor 1)
P48551,0.057,59.7,2137.247,257,1N6U;1N6V;2HYM;2KZ1;2LAG;3S8W;3S9D;3SE3;3SE4,Interferon alpha/beta receptor 2 (IFN-R-2) (IFN-alpha binding protein) (IFN-alpha/beta receptor 2) (Interferon alpha binding protein) (Type I interferon receptor 2)
P48551,0.124,-36.7,2796.763,48,1N6U;1N6V;2HYM;2KZ1;2LAG;3S8W;3S9D;3SE3;3SE4,Interferon alpha/beta receptor 2 (IFN-R-2) (IFN-alpha binding protein) (IFN-alpha/beta receptor 2) (Interferon alpha binding protein) (Type I interferon receptor 2)
P48551,0.07,7.0,1615.331,107,1N6U;1N6V;2HYM;2KZ1;2LAG;3S8W;3S9D;3SE3;3SE4,Interferon alpha/beta receptor 2 (IFN-R-2) (IFN-alpha binding protein) (IFN-alpha/beta receptor 2) (Interferon alpha binding protein) (Type I interferon receptor 2)
P48551,0.126,23.7,1118.036,20,1N6U;1N6V;2HYM;2KZ1;2LAG;3S8W;3S9D;3SE3;3SE4,Interferon alpha/beta receptor 2 (IFN-R-2) (IFN-alpha binding protein) (IFN-alpha/beta receptor 2) (Interferon alpha binding protein) (Type I interferon receptor 2)
P15260,0.096,67.3,2362.477,259,1FG9;1FYH;1JRH;6E3K;6E3L,Interferon gamma receptor 1 (IFN-gamma receptor 1) (IFN-gamma-R1) (CDw119) (Interferon gamma receptor alpha-chain) (IFN-gamma-R-alpha) (CD antigen CD119)
P15260,0.749,-15.3,1658.403,151,1FG9;1FYH;1JRH;6E3K;6E3L,Interferon gamma receptor 1 (IFN-gamma receptor 1) (IFN-gamma-R1) (CDw119) (Interferon gamma receptor alpha-chain) (IFN-gamma-R-alpha) (CD antigen CD119)
P38484,0.022,-16.4,1880.823,139,5EH1;6E3K;6E3L,Interferon gamma receptor 2 (IFN-gamma receptor 2) (IFN-gamma-R2) (Interferon gamma receptor accessory factor 1) (AF-1) (Interferon gamma receptor beta-chain) (IFN-gamma-R-beta) (Interferon gamma transducer 1)
P38484,0.582,-5.3,1465.089,105,5EH1;6E3K;6E3L,Interferon gamma receptor 2 (IFN-gamma receptor 2) (IFN-gamma-R2) (Interferon gamma receptor accessory factor 1) (AF-1) (Interferon gamma receptor beta-chain) (IFN-gamma-R-beta) (Interferon gamma transducer 1)
P38484,0.067,60.0,3360.357,263,5EH1;6E3K;6E3L,Interferon gamma receptor 2 (IFN-gamma receptor 2) (IFN-gamma-R2) (Interferon gamma receptor accessory factor 1) (AF-1) (Interferon gamma receptor beta-chain) (IFN-gamma-R-beta) (Interferon gamma transducer 1)
P38484,0.024,14.4,815.113,323,5EH1;6E3K;6E3L,Interferon gamma receptor 2 (IFN-gamma receptor 2) (IFN-gamma-R2) (Interferon gamma receptor accessory factor 1) (AF-1) (Interferon gamma receptor beta-chain) (IFN-gamma-R-beta) (Interferon gamma transducer 1)
Q8IU57,0.09,52.0,2468.415,238,3OG4;3OG6;5IXD;5IXI;5L04;5T5W,Interferon lambda receptor 1 (IFN-lambda receptor 1) (IFN-lambda-R1) (Cytokine receptor class-II member 12) (Cytokine receptor family 2 member 12) (CRF2-12) (Interleukin-28 receptor subunit alpha) (IL-28 receptor subunit alpha) (IL-28R-alpha) (IL-28RA) (Likely interleukin or cytokine receptor 2) (LICR2)
Q8IU57,0.058,-1.5,2938.391,126,3OG4;3OG6;5IXD;5IXI;5L04;5T5W,Interferon lambda receptor 1 (IFN-lambda receptor 1) (IFN-lambda-R1) (Cytokine receptor class-II member 12) (Cytokine receptor family 2 member 12) (CRF2-12) (Interleukin-28 receptor subunit alpha) (IL-28 receptor subunit alpha) (IL-28R-alpha) (IL-28RA) (Likely interleukin or cytokine receptor 2) (LICR2)
Q8IU57,0.606,19.5,886.205,11,3OG4;3OG6;5IXD;5IXI;5L04;5T5W,Interferon lambda receptor 1 (IFN-lambda receptor 1) (IFN-lambda-R1) (Cytokine receptor class-II member 12) (Cytokine receptor family 2 member 12) (CRF2-12) (Interleukin-28 receptor subunit alpha) (IL-28 receptor subunit alpha) (IL-28R-alpha) (IL-28RA) (Likely interleukin or cytokine receptor 2) (LICR2)
P00533,0.169,37.2,2385.574,663,1IVO;1M14;1M17;1MOX;1NQL;1XKK;1YY9;1Z9I;2EB2;2EB3;2GS2;2GS6;2GS7;2ITN;2ITO;2ITP;2ITQ;2ITT;2ITU;2ITV;2ITW;2ITX;2ITY;2ITZ;2J5E;2J5F;2J6M;2JIT;2JIU;2JIV;2KS1;2M0B;2M20;2N5S;2RF9;2RFD;2RFE;2RGP;3B2U;3B2V;3BEL;3BUO;3C09;3G5V;3G5Y;3GOP;3GT8;3IKA;3LZB;3NJP;3OB2;3OP0;3P0Y;3PFV;3POZ;3QWQ;3UG1;3UG2;3VJN;3VJO;3VRP;3VRR;3W2O;3W2P;3W2Q;3W2R;3W2S;3W32;3W33;4G5J;4G5P;4HJO;4I1Z;4I20;4I21;4I22;4I23;4I24;4JQ7;4JQ8;4JR3;4JRV;4KRL;4KRM;4KRO;4KRP;4LI5;4LL0;4LQM;4LRM;4R3P;4R3R;4R5S;4RIW;4RIX;4RIY;4RJ4;4RJ5;4RJ6;4RJ7;4RJ8;4TKS;4UIP;4UV7;4WD5;4WKQ;4WRG;4ZAU;4ZJV;4ZSE;5C8K;5C8M;5C8N;5CAL;5CAN;5CAO;5CAP;5CAQ;5CAS;5CAU;5CAV;5CNN;5CNO;5CZH;5CZI;5D41;5EDP;5EDQ;5EDR;5EM5;5EM6;5EM7;5EM8;5FED;5FEE;5FEQ;5GMP;5GNK;5GTY;5GTZ;5HCX;5HCY;5HCZ;5HG5;5HG7;5HG8;5HG9;5HIB;5HIC;5J9Y;5J9Z;5JEB;5LV6;5SX4;5SX5;5U8L;5UG8;5UG9;5UGA;5UGB;5UGC;5UWD;5WB7;5WB8;5X26;5X27;5X28;5X2A;5X2C;5X2F;5X2K;5XDK;5XDL;5XGM;5XGN;5XWD;5Y25;5Y9T;5YU9;5ZTO;5ZWJ;6ARU;6B3S;6D8E;6DUK;6JRJ;6JRK;6JRX;6JWL;6JX0;6JX4;6JXT;6JZ0;6LUB;6LUD;6P1D;6P1L;6P8Q;6S89;6S8A;6S9B;6S9C;6S9D;6TFU;6TFV;6TFW;6TFY;6TFZ;6TG0;6TG1;6V5N;6V5P;6V66;6V6K;6V6O;6VH4;6VHN;6VHP;6WA2;6WAK;6WXN;6XL4;6Z4B;6Z4D;7A2A;7A6I;7A6J;7A6K;7AEI;7AEM;7B85;7ER2;7JXI;7JXK;7JXL;7JXM;7JXP;7JXQ;7JXW;7K1H;7K1I;7KXZ;7KY0;7LEN;7LFR;7LFS;7LG8;7LGS;7LTX;7OM4;7OXB;7SI1;7SYD;7SYE;7SZ0;7SZ1;7SZ5;7SZ7;7TVD;7VRA;7VRE;8A27;8A2A;8A2B;8A2D;8D73;8D76,Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
P00533,0.119,15.4,1582.126,743,1IVO;1M14;1M17;1MOX;1NQL;1XKK;1YY9;1Z9I;2EB2;2EB3;2GS2;2GS6;2GS7;2ITN;2ITO;2ITP;2ITQ;2ITT;2ITU;2ITV;2ITW;2ITX;2ITY;2ITZ;2J5E;2J5F;2J6M;2JIT;2JIU;2JIV;2KS1;2M0B;2M20;2N5S;2RF9;2RFD;2RFE;2RGP;3B2U;3B2V;3BEL;3BUO;3C09;3G5V;3G5Y;3GOP;3GT8;3IKA;3LZB;3NJP;3OB2;3OP0;3P0Y;3PFV;3POZ;3QWQ;3UG1;3UG2;3VJN;3VJO;3VRP;3VRR;3W2O;3W2P;3W2Q;3W2R;3W2S;3W32;3W33;4G5J;4G5P;4HJO;4I1Z;4I20;4I21;4I22;4I23;4I24;4JQ7;4JQ8;4JR3;4JRV;4KRL;4KRM;4KRO;4KRP;4LI5;4LL0;4LQM;4LRM;4R3P;4R3R;4R5S;4RIW;4RIX;4RIY;4RJ4;4RJ5;4RJ6;4RJ7;4RJ8;4TKS;4UIP;4UV7;4WD5;4WKQ;4WRG;4ZAU;4ZJV;4ZSE;5C8K;5C8M;5C8N;5CAL;5CAN;5CAO;5CAP;5CAQ;5CAS;5CAU;5CAV;5CNN;5CNO;5CZH;5CZI;5D41;5EDP;5EDQ;5EDR;5EM5;5EM6;5EM7;5EM8;5FED;5FEE;5FEQ;5GMP;5GNK;5GTY;5GTZ;5HCX;5HCY;5HCZ;5HG5;5HG7;5HG8;5HG9;5HIB;5HIC;5J9Y;5J9Z;5JEB;5LV6;5SX4;5SX5;5U8L;5UG8;5UG9;5UGA;5UGB;5UGC;5UWD;5WB7;5WB8;5X26;5X27;5X28;5X2A;5X2C;5X2F;5X2K;5XDK;5XDL;5XGM;5XGN;5XWD;5Y25;5Y9T;5YU9;5ZTO;5ZWJ;6ARU;6B3S;6D8E;6DUK;6JRJ;6JRK;6JRX;6JWL;6JX0;6JX4;6JXT;6JZ0;6LUB;6LUD;6P1D;6P1L;6P8Q;6S89;6S8A;6S9B;6S9C;6S9D;6TFU;6TFV;6TFW;6TFY;6TFZ;6TG0;6TG1;6V5N;6V5P;6V66;6V6K;6V6O;6VH4;6VHN;6VHP;6WA2;6WAK;6WXN;6XL4;6Z4B;6Z4D;7A2A;7A6I;7A6J;7A6K;7AEI;7AEM;7B85;7ER2;7JXI;7JXK;7JXL;7JXM;7JXP;7JXQ;7JXW;7K1H;7K1I;7KXZ;7KY0;7LEN;7LFR;7LFS;7LG8;7LGS;7LTX;7OM4;7OXB;7SI1;7SYD;7SYE;7SZ0;7SZ1;7SZ5;7SZ7;7TVD;7VRA;7VRE;8A27;8A2A;8A2B;8A2D;8D73;8D76,Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
P00533,0.672,-16.9,1510.646,948,1IVO;1M14;1M17;1MOX;1NQL;1XKK;1YY9;1Z9I;2EB2;2EB3;2GS2;2GS6;2GS7;2ITN;2ITO;2ITP;2ITQ;2ITT;2ITU;2ITV;2ITW;2ITX;2ITY;2ITZ;2J5E;2J5F;2J6M;2JIT;2JIU;2JIV;2KS1;2M0B;2M20;2N5S;2RF9;2RFD;2RFE;2RGP;3B2U;3B2V;3BEL;3BUO;3C09;3G5V;3G5Y;3GOP;3GT8;3IKA;3LZB;3NJP;3OB2;3OP0;3P0Y;3PFV;3POZ;3QWQ;3UG1;3UG2;3VJN;3VJO;3VRP;3VRR;3W2O;3W2P;3W2Q;3W2R;3W2S;3W32;3W33;4G5J;4G5P;4HJO;4I1Z;4I20;4I21;4I22;4I23;4I24;4JQ7;4JQ8;4JR3;4JRV;4KRL;4KRM;4KRO;4KRP;4LI5;4LL0;4LQM;4LRM;4R3P;4R3R;4R5S;4RIW;4RIX;4RIY;4RJ4;4RJ5;4RJ6;4RJ7;4RJ8;4TKS;4UIP;4UV7;4WD5;4WKQ;4WRG;4ZAU;4ZJV;4ZSE;5C8K;5C8M;5C8N;5CAL;5CAN;5CAO;5CAP;5CAQ;5CAS;5CAU;5CAV;5CNN;5CNO;5CZH;5CZI;5D41;5EDP;5EDQ;5EDR;5EM5;5EM6;5EM7;5EM8;5FED;5FEE;5FEQ;5GMP;5GNK;5GTY;5GTZ;5HCX;5HCY;5HCZ;5HG5;5HG7;5HG8;5HG9;5HIB;5HIC;5J9Y;5J9Z;5JEB;5LV6;5SX4;5SX5;5U8L;5UG8;5UG9;5UGA;5UGB;5UGC;5UWD;5WB7;5WB8;5X26;5X27;5X28;5X2A;5X2C;5X2F;5X2K;5XDK;5XDL;5XGM;5XGN;5XWD;5Y25;5Y9T;5YU9;5ZTO;5ZWJ;6ARU;6B3S;6D8E;6DUK;6JRJ;6JRK;6JRX;6JWL;6JX0;6JX4;6JXT;6JZ0;6LUB;6LUD;6P1D;6P1L;6P8Q;6S89;6S8A;6S9B;6S9C;6S9D;6TFU;6TFV;6TFW;6TFY;6TFZ;6TG0;6TG1;6V5N;6V5P;6V66;6V6K;6V6O;6VH4;6VHN;6VHP;6WA2;6WAK;6WXN;6XL4;6Z4B;6Z4D;7A2A;7A6I;7A6J;7A6K;7AEI;7AEM;7B85;7ER2;7JXI;7JXK;7JXL;7JXM;7JXP;7JXQ;7JXW;7K1H;7K1I;7KXZ;7KY0;7LEN;7LFR;7LFS;7LG8;7LGS;7LTX;7OM4;7OXB;7SI1;7SYD;7SYE;7SZ0;7SZ1;7SZ5;7SZ7;7TVD;7VRA;7VRE;8A27;8A2A;8A2B;8A2D;8D73;8D76,Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
P00533,0.53,2.4,2002.712,599,1IVO;1M14;1M17;1MOX;1NQL;1XKK;1YY9;1Z9I;2EB2;2EB3;2GS2;2GS6;2GS7;2ITN;2ITO;2ITP;2ITQ;2ITT;2ITU;2ITV;2ITW;2ITX;2ITY;2ITZ;2J5E;2J5F;2J6M;2JIT;2JIU;2JIV;2KS1;2M0B;2M20;2N5S;2RF9;2RFD;2RFE;2RGP;3B2U;3B2V;3BEL;3BUO;3C09;3G5V;3G5Y;3GOP;3GT8;3IKA;3LZB;3NJP;3OB2;3OP0;3P0Y;3PFV;3POZ;3QWQ;3UG1;3UG2;3VJN;3VJO;3VRP;3VRR;3W2O;3W2P;3W2Q;3W2R;3W2S;3W32;3W33;4G5J;4G5P;4HJO;4I1Z;4I20;4I21;4I22;4I23;4I24;4JQ7;4JQ8;4JR3;4JRV;4KRL;4KRM;4KRO;4KRP;4LI5;4LL0;4LQM;4LRM;4R3P;4R3R;4R5S;4RIW;4RIX;4RIY;4RJ4;4RJ5;4RJ6;4RJ7;4RJ8;4TKS;4UIP;4UV7;4WD5;4WKQ;4WRG;4ZAU;4ZJV;4ZSE;5C8K;5C8M;5C8N;5CAL;5CAN;5CAO;5CAP;5CAQ;5CAS;5CAU;5CAV;5CNN;5CNO;5CZH;5CZI;5D41;5EDP;5EDQ;5EDR;5EM5;5EM6;5EM7;5EM8;5FED;5FEE;5FEQ;5GMP;5GNK;5GTY;5GTZ;5HCX;5HCY;5HCZ;5HG5;5HG7;5HG8;5HG9;5HIB;5HIC;5J9Y;5J9Z;5JEB;5LV6;5SX4;5SX5;5U8L;5UG8;5UG9;5UGA;5UGB;5UGC;5UWD;5WB7;5WB8;5X26;5X27;5X28;5X2A;5X2C;5X2F;5X2K;5XDK;5XDL;5XGM;5XGN;5XWD;5Y25;5Y9T;5YU9;5ZTO;5ZWJ;6ARU;6B3S;6D8E;6DUK;6JRJ;6JRK;6JRX;6JWL;6JX0;6JX4;6JXT;6JZ0;6LUB;6LUD;6P1D;6P1L;6P8Q;6S89;6S8A;6S9B;6S9C;6S9D;6TFU;6TFV;6TFW;6TFY;6TFZ;6TG0;6TG1;6V5N;6V5P;6V66;6V6K;6V6O;6VH4;6VHN;6VHP;6WA2;6WAK;6WXN;6XL4;6Z4B;6Z4D;7A2A;7A6I;7A6J;7A6K;7AEI;7AEM;7B85;7ER2;7JXI;7JXK;7JXL;7JXM;7JXP;7JXQ;7JXW;7K1H;7K1I;7KXZ;7KY0;7LEN;7LFR;7LFS;7LG8;7LGS;7LTX;7OM4;7OXB;7SI1;7SYD;7SYE;7SZ0;7SZ1;7SZ5;7SZ7;7TVD;7VRA;7VRE;8A27;8A2A;8A2B;8A2D;8D73;8D76,Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
P00533,0.545,-7.0,850.39,178,1IVO;1M14;1M17;1MOX;1NQL;1XKK;1YY9;1Z9I;2EB2;2EB3;2GS2;2GS6;2GS7;2ITN;2ITO;2ITP;2ITQ;2ITT;2ITU;2ITV;2ITW;2ITX;2ITY;2ITZ;2J5E;2J5F;2J6M;2JIT;2JIU;2JIV;2KS1;2M0B;2M20;2N5S;2RF9;2RFD;2RFE;2RGP;3B2U;3B2V;3BEL;3BUO;3C09;3G5V;3G5Y;3GOP;3GT8;3IKA;3LZB;3NJP;3OB2;3OP0;3P0Y;3PFV;3POZ;3QWQ;3UG1;3UG2;3VJN;3VJO;3VRP;3VRR;3W2O;3W2P;3W2Q;3W2R;3W2S;3W32;3W33;4G5J;4G5P;4HJO;4I1Z;4I20;4I21;4I22;4I23;4I24;4JQ7;4JQ8;4JR3;4JRV;4KRL;4KRM;4KRO;4KRP;4LI5;4LL0;4LQM;4LRM;4R3P;4R3R;4R5S;4RIW;4RIX;4RIY;4RJ4;4RJ5;4RJ6;4RJ7;4RJ8;4TKS;4UIP;4UV7;4WD5;4WKQ;4WRG;4ZAU;4ZJV;4ZSE;5C8K;5C8M;5C8N;5CAL;5CAN;5CAO;5CAP;5CAQ;5CAS;5CAU;5CAV;5CNN;5CNO;5CZH;5CZI;5D41;5EDP;5EDQ;5EDR;5EM5;5EM6;5EM7;5EM8;5FED;5FEE;5FEQ;5GMP;5GNK;5GTY;5GTZ;5HCX;5HCY;5HCZ;5HG5;5HG7;5HG8;5HG9;5HIB;5HIC;5J9Y;5J9Z;5JEB;5LV6;5SX4;5SX5;5U8L;5UG8;5UG9;5UGA;5UGB;5UGC;5UWD;5WB7;5WB8;5X26;5X27;5X28;5X2A;5X2C;5X2F;5X2K;5XDK;5XDL;5XGM;5XGN;5XWD;5Y25;5Y9T;5YU9;5ZTO;5ZWJ;6ARU;6B3S;6D8E;6DUK;6JRJ;6JRK;6JRX;6JWL;6JX0;6JX4;6JXT;6JZ0;6LUB;6LUD;6P1D;6P1L;6P8Q;6S89;6S8A;6S9B;6S9C;6S9D;6TFU;6TFV;6TFW;6TFY;6TFZ;6TG0;6TG1;6V5N;6V5P;6V66;6V6K;6V6O;6VH4;6VHN;6VHP;6WA2;6WAK;6WXN;6XL4;6Z4B;6Z4D;7A2A;7A6I;7A6J;7A6K;7AEI;7AEM;7B85;7ER2;7JXI;7JXK;7JXL;7JXM;7JXP;7JXQ;7JXW;7K1H;7K1I;7KXZ;7KY0;7LEN;7LFR;7LFS;7LG8;7LGS;7LTX;7OM4;7OXB;7SI1;7SYD;7SYE;7SZ0;7SZ1;7SZ5;7SZ7;7TVD;7VRA;7VRE;8A27;8A2A;8A2B;8A2D;8D73;8D76,Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
P00533,0.653,2.6,1432.349,764,1IVO;1M14;1M17;1MOX;1NQL;1XKK;1YY9;1Z9I;2EB2;2EB3;2GS2;2GS6;2GS7;2ITN;2ITO;2ITP;2ITQ;2ITT;2ITU;2ITV;2ITW;2ITX;2ITY;2ITZ;2J5E;2J5F;2J6M;2JIT;2JIU;2JIV;2KS1;2M0B;2M20;2N5S;2RF9;2RFD;2RFE;2RGP;3B2U;3B2V;3BEL;3BUO;3C09;3G5V;3G5Y;3GOP;3GT8;3IKA;3LZB;3NJP;3OB2;3OP0;3P0Y;3PFV;3POZ;3QWQ;3UG1;3UG2;3VJN;3VJO;3VRP;3VRR;3W2O;3W2P;3W2Q;3W2R;3W2S;3W32;3W33;4G5J;4G5P;4HJO;4I1Z;4I20;4I21;4I22;4I23;4I24;4JQ7;4JQ8;4JR3;4JRV;4KRL;4KRM;4KRO;4KRP;4LI5;4LL0;4LQM;4LRM;4R3P;4R3R;4R5S;4RIW;4RIX;4RIY;4RJ4;4RJ5;4RJ6;4RJ7;4RJ8;4TKS;4UIP;4UV7;4WD5;4WKQ;4WRG;4ZAU;4ZJV;4ZSE;5C8K;5C8M;5C8N;5CAL;5CAN;5CAO;5CAP;5CAQ;5CAS;5CAU;5CAV;5CNN;5CNO;5CZH;5CZI;5D41;5EDP;5EDQ;5EDR;5EM5;5EM6;5EM7;5EM8;5FED;5FEE;5FEQ;5GMP;5GNK;5GTY;5GTZ;5HCX;5HCY;5HCZ;5HG5;5HG7;5HG8;5HG9;5HIB;5HIC;5J9Y;5J9Z;5JEB;5LV6;5SX4;5SX5;5U8L;5UG8;5UG9;5UGA;5UGB;5UGC;5UWD;5WB7;5WB8;5X26;5X27;5X28;5X2A;5X2C;5X2F;5X2K;5XDK;5XDL;5XGM;5XGN;5XWD;5Y25;5Y9T;5YU9;5ZTO;5ZWJ;6ARU;6B3S;6D8E;6DUK;6JRJ;6JRK;6JRX;6JWL;6JX0;6JX4;6JXT;6JZ0;6LUB;6LUD;6P1D;6P1L;6P8Q;6S89;6S8A;6S9B;6S9C;6S9D;6TFU;6TFV;6TFW;6TFY;6TFZ;6TG0;6TG1;6V5N;6V5P;6V66;6V6K;6V6O;6VH4;6VHN;6VHP;6WA2;6WAK;6WXN;6XL4;6Z4B;6Z4D;7A2A;7A6I;7A6J;7A6K;7AEI;7AEM;7B85;7ER2;7JXI;7JXK;7JXL;7JXM;7JXP;7JXQ;7JXW;7K1H;7K1I;7KXZ;7KY0;7LEN;7LFR;7LFS;7LG8;7LGS;7LTX;7OM4;7OXB;7SI1;7SYD;7SYE;7SZ0;7SZ1;7SZ5;7SZ7;7TVD;7VRA;7VRE;8A27;8A2A;8A2B;8A2D;8D73;8D76,Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
P00533,0.565,5.1,431.582,93,1IVO;1M14;1M17;1MOX;1NQL;1XKK;1YY9;1Z9I;2EB2;2EB3;2GS2;2GS6;2GS7;2ITN;2ITO;2ITP;2ITQ;2ITT;2ITU;2ITV;2ITW;2ITX;2ITY;2ITZ;2J5E;2J5F;2J6M;2JIT;2JIU;2JIV;2KS1;2M0B;2M20;2N5S;2RF9;2RFD;2RFE;2RGP;3B2U;3B2V;3BEL;3BUO;3C09;3G5V;3G5Y;3GOP;3GT8;3IKA;3LZB;3NJP;3OB2;3OP0;3P0Y;3PFV;3POZ;3QWQ;3UG1;3UG2;3VJN;3VJO;3VRP;3VRR;3W2O;3W2P;3W2Q;3W2R;3W2S;3W32;3W33;4G5J;4G5P;4HJO;4I1Z;4I20;4I21;4I22;4I23;4I24;4JQ7;4JQ8;4JR3;4JRV;4KRL;4KRM;4KRO;4KRP;4LI5;4LL0;4LQM;4LRM;4R3P;4R3R;4R5S;4RIW;4RIX;4RIY;4RJ4;4RJ5;4RJ6;4RJ7;4RJ8;4TKS;4UIP;4UV7;4WD5;4WKQ;4WRG;4ZAU;4ZJV;4ZSE;5C8K;5C8M;5C8N;5CAL;5CAN;5CAO;5CAP;5CAQ;5CAS;5CAU;5CAV;5CNN;5CNO;5CZH;5CZI;5D41;5EDP;5EDQ;5EDR;5EM5;5EM6;5EM7;5EM8;5FED;5FEE;5FEQ;5GMP;5GNK;5GTY;5GTZ;5HCX;5HCY;5HCZ;5HG5;5HG7;5HG8;5HG9;5HIB;5HIC;5J9Y;5J9Z;5JEB;5LV6;5SX4;5SX5;5U8L;5UG8;5UG9;5UGA;5UGB;5UGC;5UWD;5WB7;5WB8;5X26;5X27;5X28;5X2A;5X2C;5X2F;5X2K;5XDK;5XDL;5XGM;5XGN;5XWD;5Y25;5Y9T;5YU9;5ZTO;5ZWJ;6ARU;6B3S;6D8E;6DUK;6JRJ;6JRK;6JRX;6JWL;6JX0;6JX4;6JXT;6JZ0;6LUB;6LUD;6P1D;6P1L;6P8Q;6S89;6S8A;6S9B;6S9C;6S9D;6TFU;6TFV;6TFW;6TFY;6TFZ;6TG0;6TG1;6V5N;6V5P;6V66;6V6K;6V6O;6VH4;6VHN;6VHP;6WA2;6WAK;6WXN;6XL4;6Z4B;6Z4D;7A2A;7A6I;7A6J;7A6K;7AEI;7AEM;7B85;7ER2;7JXI;7JXK;7JXL;7JXM;7JXP;7JXQ;7JXW;7K1H;7K1I;7KXZ;7KY0;7LEN;7LFR;7LFS;7LG8;7LGS;7LTX;7OM4;7OXB;7SI1;7SYD;7SYE;7SZ0;7SZ1;7SZ5;7SZ7;7TVD;7VRA;7VRE;8A27;8A2A;8A2B;8A2D;8D73;8D76,Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
P00533,0.623,-3.7,1367.242,549,1IVO;1M14;1M17;1MOX;1NQL;1XKK;1YY9;1Z9I;2EB2;2EB3;2GS2;2GS6;2GS7;2ITN;2ITO;2ITP;2ITQ;2ITT;2ITU;2ITV;2ITW;2ITX;2ITY;2ITZ;2J5E;2J5F;2J6M;2JIT;2JIU;2JIV;2KS1;2M0B;2M20;2N5S;2RF9;2RFD;2RFE;2RGP;3B2U;3B2V;3BEL;3BUO;3C09;3G5V;3G5Y;3GOP;3GT8;3IKA;3LZB;3NJP;3OB2;3OP0;3P0Y;3PFV;3POZ;3QWQ;3UG1;3UG2;3VJN;3VJO;3VRP;3VRR;3W2O;3W2P;3W2Q;3W2R;3W2S;3W32;3W33;4G5J;4G5P;4HJO;4I1Z;4I20;4I21;4I22;4I23;4I24;4JQ7;4JQ8;4JR3;4JRV;4KRL;4KRM;4KRO;4KRP;4LI5;4LL0;4LQM;4LRM;4R3P;4R3R;4R5S;4RIW;4RIX;4RIY;4RJ4;4RJ5;4RJ6;4RJ7;4RJ8;4TKS;4UIP;4UV7;4WD5;4WKQ;4WRG;4ZAU;4ZJV;4ZSE;5C8K;5C8M;5C8N;5CAL;5CAN;5CAO;5CAP;5CAQ;5CAS;5CAU;5CAV;5CNN;5CNO;5CZH;5CZI;5D41;5EDP;5EDQ;5EDR;5EM5;5EM6;5EM7;5EM8;5FED;5FEE;5FEQ;5GMP;5GNK;5GTY;5GTZ;5HCX;5HCY;5HCZ;5HG5;5HG7;5HG8;5HG9;5HIB;5HIC;5J9Y;5J9Z;5JEB;5LV6;5SX4;5SX5;5U8L;5UG8;5UG9;5UGA;5UGB;5UGC;5UWD;5WB7;5WB8;5X26;5X27;5X28;5X2A;5X2C;5X2F;5X2K;5XDK;5XDL;5XGM;5XGN;5XWD;5Y25;5Y9T;5YU9;5ZTO;5ZWJ;6ARU;6B3S;6D8E;6DUK;6JRJ;6JRK;6JRX;6JWL;6JX0;6JX4;6JXT;6JZ0;6LUB;6LUD;6P1D;6P1L;6P8Q;6S89;6S8A;6S9B;6S9C;6S9D;6TFU;6TFV;6TFW;6TFY;6TFZ;6TG0;6TG1;6V5N;6V5P;6V66;6V6K;6V6O;6VH4;6VHN;6VHP;6WA2;6WAK;6WXN;6XL4;6Z4B;6Z4D;7A2A;7A6I;7A6J;7A6K;7AEI;7AEM;7B85;7ER2;7JXI;7JXK;7JXL;7JXM;7JXP;7JXQ;7JXW;7K1H;7K1I;7KXZ;7KY0;7LEN;7LFR;7LFS;7LG8;7LGS;7LTX;7OM4;7OXB;7SI1;7SYD;7SYE;7SZ0;7SZ1;7SZ5;7SZ7;7TVD;7VRA;7VRE;8A27;8A2A;8A2B;8A2D;8D73;8D76,Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
P00533,0.067,-2.1,1484.174,350,1IVO;1M14;1M17;1MOX;1NQL;1XKK;1YY9;1Z9I;2EB2;2EB3;2GS2;2GS6;2GS7;2ITN;2ITO;2ITP;2ITQ;2ITT;2ITU;2ITV;2ITW;2ITX;2ITY;2ITZ;2J5E;2J5F;2J6M;2JIT;2JIU;2JIV;2KS1;2M0B;2M20;2N5S;2RF9;2RFD;2RFE;2RGP;3B2U;3B2V;3BEL;3BUO;3C09;3G5V;3G5Y;3GOP;3GT8;3IKA;3LZB;3NJP;3OB2;3OP0;3P0Y;3PFV;3POZ;3QWQ;3UG1;3UG2;3VJN;3VJO;3VRP;3VRR;3W2O;3W2P;3W2Q;3W2R;3W2S;3W32;3W33;4G5J;4G5P;4HJO;4I1Z;4I20;4I21;4I22;4I23;4I24;4JQ7;4JQ8;4JR3;4JRV;4KRL;4KRM;4KRO;4KRP;4LI5;4LL0;4LQM;4LRM;4R3P;4R3R;4R5S;4RIW;4RIX;4RIY;4RJ4;4RJ5;4RJ6;4RJ7;4RJ8;4TKS;4UIP;4UV7;4WD5;4WKQ;4WRG;4ZAU;4ZJV;4ZSE;5C8K;5C8M;5C8N;5CAL;5CAN;5CAO;5CAP;5CAQ;5CAS;5CAU;5CAV;5CNN;5CNO;5CZH;5CZI;5D41;5EDP;5EDQ;5EDR;5EM5;5EM6;5EM7;5EM8;5FED;5FEE;5FEQ;5GMP;5GNK;5GTY;5GTZ;5HCX;5HCY;5HCZ;5HG5;5HG7;5HG8;5HG9;5HIB;5HIC;5J9Y;5J9Z;5JEB;5LV6;5SX4;5SX5;5U8L;5UG8;5UG9;5UGA;5UGB;5UGC;5UWD;5WB7;5WB8;5X26;5X27;5X28;5X2A;5X2C;5X2F;5X2K;5XDK;5XDL;5XGM;5XGN;5XWD;5Y25;5Y9T;5YU9;5ZTO;5ZWJ;6ARU;6B3S;6D8E;6DUK;6JRJ;6JRK;6JRX;6JWL;6JX0;6JX4;6JXT;6JZ0;6LUB;6LUD;6P1D;6P1L;6P8Q;6S89;6S8A;6S9B;6S9C;6S9D;6TFU;6TFV;6TFW;6TFY;6TFZ;6TG0;6TG1;6V5N;6V5P;6V66;6V6K;6V6O;6VH4;6VHN;6VHP;6WA2;6WAK;6WXN;6XL4;6Z4B;6Z4D;7A2A;7A6I;7A6J;7A6K;7AEI;7AEM;7B85;7ER2;7JXI;7JXK;7JXL;7JXM;7JXP;7JXQ;7JXW;7K1H;7K1I;7KXZ;7KY0;7LEN;7LFR;7LFS;7LG8;7LGS;7LTX;7OM4;7OXB;7SI1;7SYD;7SYE;7SZ0;7SZ1;7SZ5;7SZ7;7TVD;7VRA;7VRE;8A27;8A2A;8A2B;8A2D;8D73;8D76,Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
P04626,0.643,7.7,1192.283,554,1MFG;1MFL;1MW4;1N8Z;1QR1;1S78;2A91;2JWA;2KS1;2L4K;2N2A;3BE1;3H3B;3MZW;3N85;3PP0;3RCD;3WLW;3WSQ;4GFU;4HRL;4HRM;4HRN;4NND;5K33;5KWG;5MY6;5O4G;5OB4;5TQS;6ATT;6BGT;6J71;6LBX;6OGE;7JXH;7MN5;7MN6;7MN8;7PCD,Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340)
P04626,0.158,-14.1,2062.372,601,1MFG;1MFL;1MW4;1N8Z;1QR1;1S78;2A91;2JWA;2KS1;2L4K;2N2A;3BE1;3H3B;3MZW;3N85;3PP0;3RCD;3WLW;3WSQ;4GFU;4HRL;4HRM;4HRN;4NND;5K33;5KWG;5MY6;5O4G;5OB4;5TQS;6ATT;6BGT;6J71;6LBX;6OGE;7JXH;7MN5;7MN6;7MN8;7PCD,Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340)
P04626,0.163,43.3,2118.637,668,1MFG;1MFL;1MW4;1N8Z;1QR1;1S78;2A91;2JWA;2KS1;2L4K;2N2A;3BE1;3H3B;3MZW;3N85;3PP0;3RCD;3WLW;3WSQ;4GFU;4HRL;4HRM;4HRN;4NND;5K33;5KWG;5MY6;5O4G;5OB4;5TQS;6ATT;6BGT;6J71;6LBX;6OGE;7JXH;7MN5;7MN6;7MN8;7PCD,Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340)
P04626,0.103,4.8,1874.171,314,1MFG;1MFL;1MW4;1N8Z;1QR1;1S78;2A91;2JWA;2KS1;2L4K;2N2A;3BE1;3H3B;3MZW;3N85;3PP0;3RCD;3WLW;3WSQ;4GFU;4HRL;4HRM;4HRN;4NND;5K33;5KWG;5MY6;5O4G;5OB4;5TQS;6ATT;6BGT;6J71;6LBX;6OGE;7JXH;7MN5;7MN6;7MN8;7PCD,Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340)
P04626,0.14,1.5,4475.097,863,1MFG;1MFL;1MW4;1N8Z;1QR1;1S78;2A91;2JWA;2KS1;2L4K;2N2A;3BE1;3H3B;3MZW;3N85;3PP0;3RCD;3WLW;3WSQ;4GFU;4HRL;4HRM;4HRN;4NND;5K33;5KWG;5MY6;5O4G;5OB4;5TQS;6ATT;6BGT;6J71;6LBX;6OGE;7JXH;7MN5;7MN6;7MN8;7PCD,Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340)
P04626,0.506,-13.3,1514.391,956,1MFG;1MFL;1MW4;1N8Z;1QR1;1S78;2A91;2JWA;2KS1;2L4K;2N2A;3BE1;3H3B;3MZW;3N85;3PP0;3RCD;3WLW;3WSQ;4GFU;4HRL;4HRM;4HRN;4NND;5K33;5KWG;5MY6;5O4G;5OB4;5TQS;6ATT;6BGT;6J71;6LBX;6OGE;7JXH;7MN5;7MN6;7MN8;7PCD,Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340)
P21860,0.606,-24.1,1947.108,738,1M6B;2L9U;3KEX;3LMG;3P11;4LEO;4P59;4RIW;4RIX;4RIY;5CUS;5O4O;5O7P;6KBI;6OP9;7BHE;7BHF;7D85;7MN5;7MN6;7MN8,Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3)
P21860,0.548,10.4,925.593,761,1M6B;2L9U;3KEX;3LMG;3P11;4LEO;4P59;4RIW;4RIX;4RIY;5CUS;5O4O;5O7P;6KBI;6OP9;7BHE;7BHF;7D85;7MN5;7MN6;7MN8,Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3)
P21860,0.175,23.4,2667.253,661,1M6B;2L9U;3KEX;3LMG;3P11;4LEO;4P59;4RIW;4RIX;4RIY;5CUS;5O4O;5O7P;6KBI;6OP9;7BHE;7BHF;7D85;7MN5;7MN6;7MN8,Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3)
P21860,0.761,-6.2,627.284,839,1M6B;2L9U;3KEX;3LMG;3P11;4LEO;4P59;4RIW;4RIX;4RIY;5CUS;5O4O;5O7P;6KBI;6OP9;7BHE;7BHF;7D85;7MN5;7MN6;7MN8,Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3)
P21860,0.589,-9.8,1552.736,945,1M6B;2L9U;3KEX;3LMG;3P11;4LEO;4P59;4RIW;4RIX;4RIY;5CUS;5O4O;5O7P;6KBI;6OP9;7BHE;7BHF;7D85;7MN5;7MN6;7MN8,Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3)
P21860,0.103,-7.3,1918.369,272,1M6B;2L9U;3KEX;3LMG;3P11;4LEO;4P59;4RIW;4RIX;4RIY;5CUS;5O4O;5O7P;6KBI;6OP9;7BHE;7BHF;7D85;7MN5;7MN6;7MN8,Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3)
P21860,0.211,3.4,1060.111,282,1M6B;2L9U;3KEX;3LMG;3P11;4LEO;4P59;4RIW;4RIX;4RIY;5CUS;5O4O;5O7P;6KBI;6OP9;7BHE;7BHF;7D85;7MN5;7MN6;7MN8,Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3)
P21860,0.527,1.2,1368.148,91,1M6B;2L9U;3KEX;3LMG;3P11;4LEO;4P59;4RIW;4RIX;4RIY;5CUS;5O4O;5O7P;6KBI;6OP9;7BHE;7BHF;7D85;7MN5;7MN6;7MN8,Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3)
Q15303,0.655,-16.9,1477.914,954,2AHX;2L2T;2LCX;2R4B;3BBT;3BBW;3BCE;3U2P;3U7U;3U9U,Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)]
Q15303,0.689,-4.3,1972.782,766,2AHX;2L2T;2LCX;2R4B;3BBT;3BBW;3BCE;3U2P;3U7U;3U9U,Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)]
Q15303,0.076,-14.2,2034.85,574,2AHX;2L2T;2LCX;2R4B;3BBT;3BBW;3BCE;3U2P;3U7U;3U9U,Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)]
Q15303,0.065,33.0,4155.599,677,2AHX;2L2T;2LCX;2R4B;3BBT;3BBW;3BCE;3U2P;3U7U;3U9U,Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)]
P11362,0.173,-27.8,5181.065,661,1AGW;1CVS;1EVT;1FGI;1FGK;1FQ9;1XR0;2CR3;2FGI;3C4F;3DPK;3GQI;3GQL;3JS2;3KRJ;3KRL;3KXX;3KY2;3OJV;3RHX;3TT0;4F63;4F64;4F65;4NK9;4NKA;4NKS;4RWI;4RWJ;4RWK;4RWL;4UWB;4UWC;4UWY;4V01;4V04;4V05;4WUN;4ZSA;5A46;5A4C;5AM6;5AM7;5B7V;5EW8;5FLF;5O49;5O4A;5UQ0;5UR1;5VND;5W21;5W59;5Z0S;5ZV2;6C18;6C19;6C1B;6C1C;6C1O;6ITJ;6MZQ;6MZW;6NVL;6P68;6P69;7OZB;7OZD;7OZF;7WCL,Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331)
P11362,0.125,47.5,2545.791,385,1AGW;1CVS;1EVT;1FGI;1FGK;1FQ9;1XR0;2CR3;2FGI;3C4F;3DPK;3GQI;3GQL;3JS2;3KRJ;3KRL;3KXX;3KY2;3OJV;3RHX;3TT0;4F63;4F64;4F65;4NK9;4NKA;4NKS;4RWI;4RWJ;4RWK;4RWL;4UWB;4UWC;4UWY;4V01;4V04;4V05;4WUN;4ZSA;5A46;5A4C;5AM6;5AM7;5B7V;5EW8;5FLF;5O49;5O4A;5UQ0;5UR1;5VND;5W21;5W59;5Z0S;5ZV2;6C18;6C19;6C1B;6C1C;6C1O;6ITJ;6MZQ;6MZW;6NVL;6P68;6P69;7OZB;7OZD;7OZF;7WCL,Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331)
P21802,0.058,-19.0,5046.699,665,1DJS;1E0O;1EV2;1GJO;1II4;1IIL;1NUN;1OEC;1WVZ;2FDB;2PSQ;2PVF;2PVY;2PWL;2PY3;2PZ5;2PZP;2PZR;2Q0B;3B2T;3CAF;3CLY;3CU1;3DAR;3EUU;3OJ2;3OJM;3RI1;4J23;4J95;4J96;4J97;4J98;4J99;4WV1;5EG3;5UGL;5UGX;5UHN;5UI0;6AGX;6LVK;6LVL;6V6Q;7KIA;7KIE;7OZY,Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332)
P21802,0.649,-1.6,717.347,119,1DJS;1E0O;1EV2;1GJO;1II4;1IIL;1NUN;1OEC;1WVZ;2FDB;2PSQ;2PVF;2PVY;2PWL;2PY3;2PZ5;2PZP;2PZR;2Q0B;3B2T;3CAF;3CLY;3CU1;3DAR;3EUU;3OJ2;3OJM;3RI1;4J23;4J95;4J96;4J97;4J98;4J99;4WV1;5EG3;5UGL;5UGX;5UHN;5UI0;6AGX;6LVK;6LVL;6V6Q;7KIA;7KIE;7OZY,Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332)
P21802,0.135,64.7,2378.268,387,1DJS;1E0O;1EV2;1GJO;1II4;1IIL;1NUN;1OEC;1WVZ;2FDB;2PSQ;2PVF;2PVY;2PWL;2PY3;2PZ5;2PZP;2PZR;2Q0B;3B2T;3CAF;3CLY;3CU1;3DAR;3EUU;3OJ2;3OJM;3RI1;4J23;4J95;4J96;4J97;4J98;4J99;4WV1;5EG3;5UGL;5UGX;5UHN;5UI0;6AGX;6LVK;6LVL;6V6Q;7KIA;7KIE;7OZY,Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332)
P22607,0.118,54.1,2593.043,386,1RY7;2LZL;4K33;6LVM;6PNX;7DHL,Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333)
P22607,0.065,1.8,1929.291,340,1RY7;2LZL;4K33;6LVM;6PNX;7DHL,Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333)
P22607,0.628,-32.8,3037.056,621,1RY7;2LZL;4K33;6LVM;6PNX;7DHL,Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333)
P22607,0.488,-5.3,1092.278,556,1RY7;2LZL;4K33;6LVM;6PNX;7DHL,Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333)
P22455,0.125,39.3,2536.316,379,4QQ5;4QQC;4QQJ;4QQT;4QRC;4R6V;4TYE;4TYG;4TYI;4TYJ;4UXQ;4XCU;5JKG;5NUD;5NWZ;5XFF;5XFJ;6IUO;6IUP;6J6Y;6JPE;6JPJ;6NVG;6NVH;6NVI;6NVJ;6NVK;6V9C;6YI8;7DTZ;7F3M;7N1J;7TYD;7V29;7VJL;7WCT;7WCW;7WCX;7YBO;7YBP;7YBX;7YC1;7YC3,Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334)
P22455,0.124,0.9,2618.601,334,4QQ5;4QQC;4QQJ;4QQT;4QRC;4R6V;4TYE;4TYG;4TYI;4TYJ;4UXQ;4XCU;5JKG;5NUD;5NWZ;5XFF;5XFJ;6IUO;6IUP;6J6Y;6JPE;6JPJ;6NVG;6NVH;6NVI;6NVJ;6NVK;6V9C;6YI8;7DTZ;7F3M;7N1J;7TYD;7V29;7VJL;7WCT;7WCW;7WCX;7YBO;7YBP;7YBX;7YC1;7YC3,Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334)
P22455,0.732,1.9,918.581,519,4QQ5;4QQC;4QQJ;4QQT;4QRC;4R6V;4TYE;4TYG;4TYI;4TYJ;4UXQ;4XCU;5JKG;5NUD;5NWZ;5XFF;5XFJ;6IUO;6IUP;6J6Y;6JPE;6JPJ;6NVG;6NVH;6NVI;6NVJ;6NVK;6V9C;6YI8;7DTZ;7F3M;7N1J;7TYD;7V29;7VJL;7WCT;7WCW;7WCX;7YBO;7YBP;7YBX;7YC1;7YC3,Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334)
P22455,0.033,-8.4,2398.195,617,4QQ5;4QQC;4QQJ;4QQT;4QRC;4R6V;4TYE;4TYG;4TYI;4TYJ;4UXQ;4XCU;5JKG;5NUD;5NWZ;5XFF;5XFJ;6IUO;6IUP;6J6Y;6JPE;6JPJ;6NVG;6NVH;6NVI;6NVJ;6NVK;6V9C;6YI8;7DTZ;7F3M;7N1J;7TYD;7V29;7VJL;7WCT;7WCW;7WCX;7YBO;7YBP;7YBX;7YC1;7YC3,Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334)
O75578,0.118,61.4,2760.979,1136,,
O75578,0.011,-24.1,3012.545,841,,
O75578,0.184,-55.2,5833.85,374,,
Q9UKX5,0.045,-73.5,4575.722,386,,
Q9UKX5,0.54,-10.0,974.412,526,,
Q9UKX5,0.03,-14.0,1501.665,766,,
Q9UKX5,0.709,2.1,545.547,959,,
Q9UKX5,0.16,44.3,2321.832,1154,,
P56199,0.567,0.3,2328.293,1016,1PT6;1QC5;1QCY;2L8S;2M32;4A0Q;5HGJ,Integrin alpha-1 (CD49 antigen-like family member A) (Laminin and collagen receptor) (VLA-1) (CD antigen CD49a)
P56199,0.148,68.3,2897.851,1156,1PT6;1QC5;1QCY;2L8S;2M32;4A0Q;5HGJ,Integrin alpha-1 (CD49 antigen-like family member A) (Laminin and collagen receptor) (VLA-1) (CD antigen CD49a)
P56199,0.624,-19.1,1508.373,987,1PT6;1QC5;1QCY;2L8S;2M32;4A0Q;5HGJ,Integrin alpha-1 (CD49 antigen-like family member A) (Laminin and collagen receptor) (VLA-1) (CD antigen CD49a)
P56199,0.017,-26.5,1839.867,919,1PT6;1QC5;1QCY;2L8S;2M32;4A0Q;5HGJ,Integrin alpha-1 (CD49 antigen-like family member A) (Laminin and collagen receptor) (VLA-1) (CD antigen CD49a)
P56199,0.667,-32.0,3351.722,133,1PT6;1QC5;1QCY;2L8S;2M32;4A0Q;5HGJ,Integrin alpha-1 (CD49 antigen-like family member A) (Laminin and collagen receptor) (VLA-1) (CD antigen CD49a)
P56199,0.043,-6.9,605.646,312,1PT6;1QC5;1QCY;2L8S;2M32;4A0Q;5HGJ,Integrin alpha-1 (CD49 antigen-like family member A) (Laminin and collagen receptor) (VLA-1) (CD antigen CD49a)
P17301,0.066,-32.0,2039.405,216,1AOX;1DZI;1V7P;4BJ3;5HJ2;5THP;6ND8;6ND9;6NDA;6NDB;6NDC;6NDD;6NDE;6NDF;6NDG;6NDH,Integrin alpha-2 (CD49 antigen-like family member B) (Collagen receptor) (Platelet membrane glycoprotein Ia) (GPIa) (VLA-2 subunit alpha) (CD antigen CD49b)
P17301,0.616,-62.1,4170.385,383,1AOX;1DZI;1V7P;4BJ3;5HJ2;5THP;6ND8;6ND9;6NDA;6NDB;6NDC;6NDD;6NDE;6NDF;6NDG;6NDH,Integrin alpha-2 (CD49 antigen-like family member B) (Collagen receptor) (Platelet membrane glycoprotein Ia) (GPIa) (VLA-2 subunit alpha) (CD antigen CD49b)
P17301,0.615,-9.2,795.233,988,1AOX;1DZI;1V7P;4BJ3;5HJ2;5THP;6ND8;6ND9;6NDA;6NDB;6NDC;6NDD;6NDE;6NDF;6NDG;6NDH,Integrin alpha-2 (CD49 antigen-like family member B) (Collagen receptor) (Platelet membrane glycoprotein Ia) (GPIa) (VLA-2 subunit alpha) (CD antigen CD49b)
P17301,0.128,65.7,2425.66,1145,1AOX;1DZI;1V7P;4BJ3;5HJ2;5THP;6ND8;6ND9;6NDA;6NDB;6NDC;6NDD;6NDE;6NDF;6NDG;6NDH,Integrin alpha-2 (CD49 antigen-like family member B) (Collagen receptor) (Platelet membrane glycoprotein Ia) (GPIa) (VLA-2 subunit alpha) (CD antigen CD49b)
P08514,0.121,-8.5,2287.803,984,1DPK;1DPQ;1KUP;1KUZ;1M8O;1S4W;1TYE;2K1A;2K9J;2KNC;2MTP;2N9Y;2VC2;2VDK;2VDL;2VDM;2VDN;2VDO;2VDP;2VDQ;2VDR;3FCS;3FCU;3NID;3NIF;3NIG;3T3M;3T3P;3ZDX;3ZDY;3ZDZ;3ZE0;3ZE1;3ZE2;4CAK;4Z7N;4Z7O;4Z7Q;5HDB;6V4P;7KN0;7L8P;7LA4;7TCT;7TD8;7THO;7TMZ;7TPD;7U60;7U9F;7U9V;7UBR;7UCY;7UDG;7UDH;7UE0;7UFH;7UH8;7UJE;7UJK;7UK9;7UKO;7UKP;7UKT,"Integrin alpha-IIb (GPalpha IIb) (GPIIb) (Platelet membrane glycoprotein IIb) (CD antigen CD41) [Cleaved into: Integrin alpha-IIb heavy chain; Integrin alpha-IIb light chain, form 1; Integrin alpha-IIb light chain, form 2]"
P08514,0.112,69.6,2887.546,1008,1DPK;1DPQ;1KUP;1KUZ;1M8O;1S4W;1TYE;2K1A;2K9J;2KNC;2MTP;2N9Y;2VC2;2VDK;2VDL;2VDM;2VDN;2VDO;2VDP;2VDQ;2VDR;3FCS;3FCU;3NID;3NIF;3NIG;3T3M;3T3P;3ZDX;3ZDY;3ZDZ;3ZE0;3ZE1;3ZE2;4CAK;4Z7N;4Z7O;4Z7Q;5HDB;6V4P;7KN0;7L8P;7LA4;7TCT;7TD8;7THO;7TMZ;7TPD;7U60;7U9F;7U9V;7UBR;7UCY;7UDG;7UDH;7UE0;7UFH;7UH8;7UJE;7UJK;7UK9;7UKO;7UKP;7UKT,"Integrin alpha-IIb (GPalpha IIb) (GPIIb) (Platelet membrane glycoprotein IIb) (CD antigen CD41) [Cleaved into: Integrin alpha-IIb heavy chain; Integrin alpha-IIb light chain, form 1; Integrin alpha-IIb light chain, form 2]"
P08514,0.718,1.1,1404.207,436,1DPK;1DPQ;1KUP;1KUZ;1M8O;1S4W;1TYE;2K1A;2K9J;2KNC;2MTP;2N9Y;2VC2;2VDK;2VDL;2VDM;2VDN;2VDO;2VDP;2VDQ;2VDR;3FCS;3FCU;3NID;3NIF;3NIG;3T3M;3T3P;3ZDX;3ZDY;3ZDZ;3ZE0;3ZE1;3ZE2;4CAK;4Z7N;4Z7O;4Z7Q;5HDB;6V4P;7KN0;7L8P;7LA4;7TCT;7TD8;7THO;7TMZ;7TPD;7U60;7U9F;7U9V;7UBR;7UCY;7UDG;7UDH;7UE0;7UFH;7UH8;7UJE;7UJK;7UK9;7UKO;7UKP;7UKT,"Integrin alpha-IIb (GPalpha IIb) (GPIIb) (Platelet membrane glycoprotein IIb) (CD antigen CD41) [Cleaved into: Integrin alpha-IIb heavy chain; Integrin alpha-IIb light chain, form 1; Integrin alpha-IIb light chain, form 2]"
P08514,0.616,-39.2,3589.955,265,1DPK;1DPQ;1KUP;1KUZ;1M8O;1S4W;1TYE;2K1A;2K9J;2KNC;2MTP;2N9Y;2VC2;2VDK;2VDL;2VDM;2VDN;2VDO;2VDP;2VDQ;2VDR;3FCS;3FCU;3NID;3NIF;3NIG;3T3M;3T3P;3ZDX;3ZDY;3ZDZ;3ZE0;3ZE1;3ZE2;4CAK;4Z7N;4Z7O;4Z7Q;5HDB;6V4P;7KN0;7L8P;7LA4;7TCT;7TD8;7THO;7TMZ;7TPD;7U60;7U9F;7U9V;7UBR;7UCY;7UDG;7UDH;7UE0;7UFH;7UH8;7UJE;7UJK;7UK9;7UKO;7UKP;7UKT,"Integrin alpha-IIb (GPalpha IIb) (GPIIb) (Platelet membrane glycoprotein IIb) (CD antigen CD41) [Cleaved into: Integrin alpha-IIb heavy chain; Integrin alpha-IIb light chain, form 1; Integrin alpha-IIb light chain, form 2]"
P08514,0.597,-19.6,1191.488,252,1DPK;1DPQ;1KUP;1KUZ;1M8O;1S4W;1TYE;2K1A;2K9J;2KNC;2MTP;2N9Y;2VC2;2VDK;2VDL;2VDM;2VDN;2VDO;2VDP;2VDQ;2VDR;3FCS;3FCU;3NID;3NIF;3NIG;3T3M;3T3P;3ZDX;3ZDY;3ZDZ;3ZE0;3ZE1;3ZE2;4CAK;4Z7N;4Z7O;4Z7Q;5HDB;6V4P;7KN0;7L8P;7LA4;7TCT;7TD8;7THO;7TMZ;7TPD;7U60;7U9F;7U9V;7UBR;7UCY;7UDG;7UDH;7UE0;7UFH;7UH8;7UJE;7UJK;7UK9;7UKO;7UKP;7UKT,"Integrin alpha-IIb (GPalpha IIb) (GPIIb) (Platelet membrane glycoprotein IIb) (CD antigen CD41) [Cleaved into: Integrin alpha-IIb heavy chain; Integrin alpha-IIb light chain, form 1; Integrin alpha-IIb light chain, form 2]"
P08514,0.146,6.5,873.353,101,1DPK;1DPQ;1KUP;1KUZ;1M8O;1S4W;1TYE;2K1A;2K9J;2KNC;2MTP;2N9Y;2VC2;2VDK;2VDL;2VDM;2VDN;2VDO;2VDP;2VDQ;2VDR;3FCS;3FCU;3NID;3NIF;3NIG;3T3M;3T3P;3ZDX;3ZDY;3ZDZ;3ZE0;3ZE1;3ZE2;4CAK;4Z7N;4Z7O;4Z7Q;5HDB;6V4P;7KN0;7L8P;7LA4;7TCT;7TD8;7THO;7TMZ;7TPD;7U60;7U9F;7U9V;7UBR;7UCY;7UDG;7UDH;7UE0;7UFH;7UH8;7UJE;7UJK;7UK9;7UKO;7UKP;7UKT,"Integrin alpha-IIb (GPalpha IIb) (GPIIb) (Platelet membrane glycoprotein IIb) (CD antigen CD41) [Cleaved into: Integrin alpha-IIb heavy chain; Integrin alpha-IIb light chain, form 1; Integrin alpha-IIb light chain, form 2]"
P26006,0.093,69.3,2770.642,1005,,
P26006,0.057,-17.3,1233.547,954,,
P26006,0.528,6.4,612.986,749,,
P26006,0.672,-62.5,3940.334,201,,
P26006,0.731,-4.2,1334.338,513,,
P26006,0.664,-22.9,790.044,445,,
P13612,0.745,1.4,692.438,937,3V4P;3V4V;4HKC;5C7Z;5FPI,Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (VLA-4 subunit alpha) (CD antigen CD49d)
P13612,0.087,44.1,3776.943,988,3V4P;3V4V;4HKC;5C7Z;5FPI,Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (VLA-4 subunit alpha) (CD antigen CD49d)
P13612,0.036,-6.9,4587.281,715,3V4P;3V4V;4HKC;5C7Z;5FPI,Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (VLA-4 subunit alpha) (CD antigen CD49d)
P13612,0.56,-56.6,3068.114,202,3V4P;3V4V;4HKC;5C7Z;5FPI,Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (VLA-4 subunit alpha) (CD antigen CD49d)
P13612,0.663,-1.8,622.309,514,3V4P;3V4V;4HKC;5C7Z;5FPI,Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (VLA-4 subunit alpha) (CD antigen CD49d)
P08648,0.075,-9.1,1972.457,768,3VI3;3VI4;4WJK;4WK0;4WK2;4WK4;7NWL;7NXD,Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain]
P08648,0.117,75.0,2916.022,1012,3VI3;3VI4;4WJK;4WK0;4WK2;4WK4;7NWL;7NXD,Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain]
P08648,0.464,-58.7,5716.081,274,3VI3;3VI4;4WJK;4WK0;4WK2;4WK4;7NWL;7NXD,Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain]
P08648,0.685,1.7,724.261,251,3VI3;3VI4;4WJK;4WK0;4WK2;4WK4;7NWL;7NXD,Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain]
P23229,0.634,-18.2,673.762,480,7CEB;7CEC,Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6 (Alpha6p)]
P23229,0.04,-17.2,3263.639,838,7CEB;7CEC,Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6 (Alpha6p)]
P23229,0.542,-68.2,4469.968,46,7CEB;7CEC,Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6 (Alpha6p)]
P23229,0.117,67.1,2969.414,1065,7CEB;7CEC,Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6 (Alpha6p)]
Q13683,0.088,59.8,2206.428,1094,,
Q13683,0.667,23.3,4511.315,1057,,
Q13683,0.685,-55.0,3739.985,201,,
P53708,0.138,75.6,2879.999,1025,,
P53708,0.539,-10.2,1024.211,824,,
P53708,0.124,-19.5,1329.708,691,,
P53708,0.117,-46.2,4491.978,289,,
P53708,0.581,0.1,1041.152,569,,
P53708,0.567,-1.4,1324.734,128,,
Q13797,0.144,76.4,2652.811,993,,
Q13797,0.078,-22.5,5396.306,741,,
Q13797,0.661,0.1,956.18,775,,
Q13797,0.616,-76.8,3500.513,249,,
Q13349,0.545,11.2,1191.621,229,,
Q13349,0.687,-42.6,3766.459,355,,
Q13349,0.091,56.8,2746.624,1112,,
Q13349,0.07,-29.5,2148.696,922,,
Q13349,0.607,1.2,1118.154,802,,
P38570,0.592,-23.4,3381.436,94,,
P38570,0.13,63.3,2815.336,1138,,
P38570,0.6,12.3,447.797,975,,
P38570,0.055,-16.1,3295.365,810,,
P38570,0.045,4.0,1661.766,944,,
P20701,0.013,49.2,7983.447,935,1CQP;1DGQ;1LFA;1MJN;1MQ8;1MQ9;1MQA;1RD4;1T0P;1XDD;1XDG;1XUO;1ZON;1ZOO;1ZOP;2ICA;2K8O;2M3E;2O7N;3BN3;3BQM;3BQN;3E2M;3EOA;3EOB;3F74;3F78;3HI6;3M6F;3TCX;4IXD;5E6R;5E6S;5E6U;6BXB;6BXF;6BXJ;6CKB;7KC3;7KC5;7KC6,Integrin alpha-L (CD11 antigen-like family member A) (Leukocyte adhesion glycoprotein LFA-1 alpha chain) (LFA-1A) (Leukocyte function-associated molecule 1 alpha chain) (CD antigen CD11a)
P20701,0.542,9.3,494.548,653,1CQP;1DGQ;1LFA;1MJN;1MQ8;1MQ9;1MQA;1RD4;1T0P;1XDD;1XDG;1XUO;1ZON;1ZOO;1ZOP;2ICA;2K8O;2M3E;2O7N;3BN3;3BQM;3BQN;3E2M;3EOA;3EOB;3F74;3F78;3HI6;3M6F;3TCX;4IXD;5E6R;5E6S;5E6U;6BXB;6BXF;6BXJ;6CKB;7KC3;7KC5;7KC6,Integrin alpha-L (CD11 antigen-like family member A) (Leukocyte adhesion glycoprotein LFA-1 alpha chain) (LFA-1A) (Leukocyte function-associated molecule 1 alpha chain) (CD antigen CD11a)
P20701,0.717,-19.8,3021.88,406,1CQP;1DGQ;1LFA;1MJN;1MQ8;1MQ9;1MQA;1RD4;1T0P;1XDD;1XDG;1XUO;1ZON;1ZOO;1ZOP;2ICA;2K8O;2M3E;2O7N;3BN3;3BQM;3BQN;3E2M;3EOA;3EOB;3F74;3F78;3HI6;3M6F;3TCX;4IXD;5E6R;5E6S;5E6U;6BXB;6BXF;6BXJ;6CKB;7KC3;7KC5;7KC6,Integrin alpha-L (CD11 antigen-like family member A) (Leukocyte adhesion glycoprotein LFA-1 alpha chain) (LFA-1A) (Leukocyte function-associated molecule 1 alpha chain) (CD antigen CD11a)
P11215,0.664,-54.2,2903.263,406,1BHO;1BHQ;1IDN;1IDO;1JLM;1M1U;1MF7;1N9Z;1NA5;2LKE;2LKJ;3Q3G;3QA3;4M76;4XW2;6RHW;7AKK;7P2D;7USL;7USM,Integrin alpha-M (CD11 antigen-like family member B) (CR-3 alpha chain) (Cell surface glycoprotein MAC-1 subunit alpha) (Leukocyte adhesion receptor MO1) (Neutrophil adherence receptor) (CD antigen CD11b)
P11215,0.045,0.3,906.726,158,1BHO;1BHQ;1IDN;1IDO;1JLM;1M1U;1MF7;1N9Z;1NA5;2LKE;2LKJ;3Q3G;3QA3;4M76;4XW2;6RHW;7AKK;7P2D;7USL;7USM,Integrin alpha-M (CD11 antigen-like family member B) (CR-3 alpha chain) (Cell surface glycoprotein MAC-1 subunit alpha) (Leukocyte adhesion receptor MO1) (Neutrophil adherence receptor) (CD antigen CD11b)
P11215,0.572,-7.1,1446.914,761,1BHO;1BHQ;1IDN;1IDO;1JLM;1M1U;1MF7;1N9Z;1NA5;2LKE;2LKJ;3Q3G;3QA3;4M76;4XW2;6RHW;7AKK;7P2D;7USL;7USM,Integrin alpha-M (CD11 antigen-like family member B) (CR-3 alpha chain) (Cell surface glycoprotein MAC-1 subunit alpha) (Leukocyte adhesion receptor MO1) (Neutrophil adherence receptor) (CD antigen CD11b)
P11215,0.553,-8.8,977.658,963,1BHO;1BHQ;1IDN;1IDO;1JLM;1M1U;1MF7;1N9Z;1NA5;2LKE;2LKJ;3Q3G;3QA3;4M76;4XW2;6RHW;7AKK;7P2D;7USL;7USM,Integrin alpha-M (CD11 antigen-like family member B) (CR-3 alpha chain) (Cell surface glycoprotein MAC-1 subunit alpha) (Leukocyte adhesion receptor MO1) (Neutrophil adherence receptor) (CD antigen CD11b)
P11215,0.017,31.7,5232.25,938,1BHO;1BHQ;1IDN;1IDO;1JLM;1M1U;1MF7;1N9Z;1NA5;2LKE;2LKJ;3Q3G;3QA3;4M76;4XW2;6RHW;7AKK;7P2D;7USL;7USM,Integrin alpha-M (CD11 antigen-like family member B) (CR-3 alpha chain) (Cell surface glycoprotein MAC-1 subunit alpha) (Leukocyte adhesion receptor MO1) (Neutrophil adherence receptor) (CD antigen CD11b)
P06756,0.102,68.7,2803.785,1005,1JV2;1L5G;1M1X;1U8C;3IJE;4G1E;4G1M;4MMX;4MMY;4MMZ;4O02;4UM8;4UM9;5FFG;5FFO;5NEM;5NER;5NET;5NEU;6AVQ;6AVR;6AVU;6DJP;6MK0;6MSL;6MSU;6NAJ;6OM1;6OM2;6UJA;6UJB;6UJC;7Y1T,Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain]
P06756,0.64,-2.3,1135.067,778,1JV2;1L5G;1M1X;1U8C;3IJE;4G1E;4G1M;4MMX;4MMY;4MMZ;4O02;4UM8;4UM9;5FFG;5FFO;5NEM;5NER;5NET;5NEU;6AVQ;6AVR;6AVU;6DJP;6MK0;6MSL;6MSU;6NAJ;6OM1;6OM2;6UJA;6UJB;6UJC;7Y1T,Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain]
P06756,0.536,-14.0,2479.103,504,1JV2;1L5G;1M1X;1U8C;3IJE;4G1E;4G1M;4MMX;4MMY;4MMZ;4O02;4UM8;4UM9;5FFG;5FFO;5NEM;5NER;5NET;5NEU;6AVQ;6AVR;6AVU;6DJP;6MK0;6MSL;6MSU;6NAJ;6OM1;6OM2;6UJA;6UJB;6UJC;7Y1T,Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain]
P06756,0.065,-1.4,1381.69,418,1JV2;1L5G;1M1X;1U8C;3IJE;4G1E;4G1M;4MMX;4MMY;4MMZ;4O02;4UM8;4UM9;5FFG;5FFO;5NEM;5NER;5NET;5NEU;6AVQ;6AVR;6AVU;6DJP;6MK0;6MSL;6MSU;6NAJ;6OM1;6OM2;6UJA;6UJB;6UJC;7Y1T,Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain]
P06756,0.495,-27.3,4042.936,254,1JV2;1L5G;1M1X;1U8C;3IJE;4G1E;4G1M;4MMX;4MMY;4MMZ;4O02;4UM8;4UM9;5FFG;5FFO;5NEM;5NER;5NET;5NEU;6AVQ;6AVR;6AVU;6DJP;6MK0;6MSL;6MSU;6NAJ;6OM1;6OM2;6UJA;6UJB;6UJC;7Y1T,Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain]
P20702,0.085,45.9,3128.946,1113,1N3Y;2LUV;3K6S;3K71;3K72;4NEH;4NEN;5ES4,"Integrin alpha-X (CD11 antigen-like family member C) (Leu M5) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c)"
P20702,0.711,-48.2,3340.797,370,1N3Y;2LUV;3K6S;3K71;3K72;4NEH;4NEN;5ES4,"Integrin alpha-X (CD11 antigen-like family member C) (Leu M5) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c)"
P20702,0.492,-9.9,1336.511,139,1N3Y;2LUV;3K6S;3K71;3K72;4NEH;4NEN;5ES4,"Integrin alpha-X (CD11 antigen-like family member C) (Leu M5) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c)"
P20702,0.553,-14.2,1616.07,961,1N3Y;2LUV;3K6S;3K71;3K72;4NEH;4NEN;5ES4,"Integrin alpha-X (CD11 antigen-like family member C) (Leu M5) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c)"
P05556,0.709,-7.0,2897.295,217,3G9W;3T9K;3VI3;3VI4;4DX9;4WJK;4WK0;4WK2;4WK4;7CEB;7CEC;7NWL;7NXD,Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29)
P05556,0.041,-24.7,2948.614,352,3G9W;3T9K;3VI3;3VI4;4DX9;4WJK;4WK0;4WK2;4WK4;7CEB;7CEC;7NWL;7NXD,Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29)
P05556,0.057,2.9,1013.152,784,3G9W;3T9K;3VI3;3VI4;4DX9;4WJK;4WK0;4WK2;4WK4;7CEB;7CEC;7NWL;7NXD,Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29)
P05556,0.053,62.4,3676.482,747,3G9W;3T9K;3VI3;3VI4;4DX9;4WJK;4WK0;4WK2;4WK4;7CEB;7CEC;7NWL;7NXD,Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29)
P05556,0.096,-29.4,3543.787,58,3G9W;3T9K;3VI3;3VI4;4DX9;4WJK;4WK0;4WK2;4WK4;7CEB;7CEC;7NWL;7NXD,Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29)
P05107,0.056,63.1,3030.379,714,1L3Y;1YUK;2JF1;2P26;2P28;2V7D;3K6S;3K71;3K72;4NEH;4NEN;5E6R;5E6S;5E6U;5E6V;5E6W;5E6X;5ES4;5XR1;5ZAZ,"Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18)"
P05107,0.049,-27.7,2697.924,304,1L3Y;1YUK;2JF1;2P26;2P28;2V7D;3K6S;3K71;3K72;4NEH;4NEN;5E6R;5E6S;5E6U;5E6V;5E6W;5E6X;5ES4;5XR1;5ZAZ,"Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18)"
P05107,0.127,-28.9,4599.398,28,1L3Y;1YUK;2JF1;2P26;2P28;2V7D;3K6S;3K71;3K72;4NEH;4NEN;5E6R;5E6S;5E6U;5E6V;5E6W;5E6X;5ES4;5XR1;5ZAZ,"Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18)"
P05106,0.649,-70.9,9061.051,589,1JV2;1KUP;1KUZ;1L5G;1M1X;1M8O;1MIZ;1MK7;1MK9;1S4X;1TYE;1U8C;2K9J;2KNC;2KV9;2L1C;2L91;2LJD;2LJE;2LJF;2MTP;2N9Y;2Q6W;2RMZ;2RN0;2VC2;2VDK;2VDL;2VDM;2VDN;2VDO;2VDP;2VDQ;2VDR;3FCS;3FCU;3IJE;3NID;3NIF;3NIG;3T3M;3T3P;3ZDX;3ZDY;3ZDZ;3ZE0;3ZE1;3ZE2;4CAK;4G1E;4G1M;4MMX;4MMY;4MMZ;4O02;4Z7N;4Z7O;4Z7Q;5HDB;6AVQ;6AVR;6AVU;6BXB;6BXF;6BXJ;6CKB;6MK0;6MSL;6MSU;6NAJ;6V4P;7KN0;7L8P;7LA4;7TCT;7TD8;7THO;7TMZ;7TPD;7U60;7U9F;7U9V;7UBR;7UCY;7UDG;7UDH;7UE0;7UFH;7UH8;7UJE;7UJK;7UK9;7UKO;7UKP;7UKT,Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61)
P05106,0.085,69.8,3062.528,732,1JV2;1KUP;1KUZ;1L5G;1M1X;1M8O;1MIZ;1MK7;1MK9;1S4X;1TYE;1U8C;2K9J;2KNC;2KV9;2L1C;2L91;2LJD;2LJE;2LJF;2MTP;2N9Y;2Q6W;2RMZ;2RN0;2VC2;2VDK;2VDL;2VDM;2VDN;2VDO;2VDP;2VDQ;2VDR;3FCS;3FCU;3IJE;3NID;3NIF;3NIG;3T3M;3T3P;3ZDX;3ZDY;3ZDZ;3ZE0;3ZE1;3ZE2;4CAK;4G1E;4G1M;4MMX;4MMY;4MMZ;4O02;4Z7N;4Z7O;4Z7Q;5HDB;6AVQ;6AVR;6AVU;6BXB;6BXF;6BXJ;6CKB;6MK0;6MSL;6MSU;6NAJ;6V4P;7KN0;7L8P;7LA4;7TCT;7TD8;7THO;7TMZ;7TPD;7U60;7U9F;7U9V;7UBR;7UCY;7UDG;7UDH;7UE0;7UFH;7UH8;7UJE;7UJK;7UK9;7UKO;7UKP;7UKT,Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61)
P16144,0.528,-4.8,2355.067,37,1QG3;2YRZ;3F7P;3F7Q;3F7R;3FQ4;3FSO;3H6A;4Q58;4WTW;4WTX;6GVK;6GVL,Integrin beta-4 (GP150) (CD antigen CD104)
P16144,0.049,-22.8,2439.217,1271,1QG3;2YRZ;3F7P;3F7Q;3F7R;3FQ4;3FSO;3H6A;4Q58;4WTW;4WTX;6GVK;6GVL,Integrin beta-4 (GP150) (CD antigen CD104)
P16144,0.114,-51.5,3249.31,311,1QG3;2YRZ;3F7P;3F7Q;3F7R;3FQ4;3FSO;3H6A;4Q58;4WTW;4WTX;6GVK;6GVL,Integrin beta-4 (GP150) (CD antigen CD104)
P16144,0.51,-2.6,4200.882,931,1QG3;2YRZ;3F7P;3F7Q;3F7R;3FQ4;3FSO;3H6A;4Q58;4WTW;4WTX;6GVK;6GVL,Integrin beta-4 (GP150) (CD antigen CD104)
P16144,0.634,-4.8,691.06,184,1QG3;2YRZ;3F7P;3F7Q;3F7R;3FQ4;3FSO;3H6A;4Q58;4WTW;4WTX;6GVK;6GVL,Integrin beta-4 (GP150) (CD antigen CD104)
P16144,0.142,7.7,1117.683,629,1QG3;2YRZ;3F7P;3F7Q;3F7R;3FQ4;3FSO;3H6A;4Q58;4WTW;4WTX;6GVK;6GVL,Integrin beta-4 (GP150) (CD antigen CD104)
P16144,0.722,-9.4,1135.414,1057,1QG3;2YRZ;3F7P;3F7Q;3F7R;3FQ4;3FSO;3H6A;4Q58;4WTW;4WTX;6GVK;6GVL,Integrin beta-4 (GP150) (CD antigen CD104)
P16144,0.176,56.6,1944.24,725,1QG3;2YRZ;3F7P;3F7Q;3F7R;3FQ4;3FSO;3H6A;4Q58;4WTW;4WTX;6GVK;6GVL,Integrin beta-4 (GP150) (CD antigen CD104)
P18084,0.664,13.5,1077.371,589,7S46;7S47;7S48,Integrin beta-5
P18084,0.52,2.6,1015.208,41,7S46;7S47;7S48,Integrin beta-5
P18084,0.042,-20.5,5127.377,348,7S46;7S47;7S48,Integrin beta-5
P18084,0.088,71.7,2635.618,733,7S46;7S47;7S48,Integrin beta-5
P18564,0.031,9.1,1357.002,120,4UM8;4UM9;5FFG;5FFO;5NEM;5NER;5NET;5NEU,Integrin beta-6
P18564,0.651,-4.0,1588.673,532,4UM8;4UM9;5FFG;5FFO;5NEM;5NER;5NET;5NEU,Integrin beta-6
P18564,0.693,-28.6,3927.614,346,4UM8;4UM9;5FFG;5FFO;5NEM;5NER;5NET;5NEU,Integrin beta-6
P18564,0.747,-8.0,1178.417,207,4UM8;4UM9;5FFG;5FFO;5NEM;5NER;5NET;5NEU,Integrin beta-6
P18564,0.08,64.0,2837.181,721,4UM8;4UM9;5FFG;5FFO;5NEM;5NER;5NET;5NEU,Integrin beta-6
P26010,0.12,-24.0,1868.997,509,2BRQ;3V4P;3V4V,Integrin beta-7 (Gut homing receptor beta subunit)
P26010,0.064,-14.9,3156.57,292,2BRQ;3V4P;3V4V,Integrin beta-7 (Gut homing receptor beta subunit)
P26010,0.061,31.7,3437.948,742,2BRQ;3V4P;3V4V,Integrin beta-7 (Gut homing receptor beta subunit)
P26012,0.099,55.9,3463.969,697,6DJP;6OM1;6OM2;6UJA;6UJB;6UJC;7Y1T,Integrin beta-8
P26012,0.145,-2.2,737.532,248,6DJP;6OM1;6OM2;6UJA;6UJB;6UJC;7Y1T,Integrin beta-8
P26012,0.049,-16.9,2705.177,325,6DJP;6OM1;6OM2;6UJA;6UJB;6UJC;7Y1T,Integrin beta-8
P26012,0.69,-1.8,2220.965,222,6DJP;6OM1;6OM2;6UJA;6UJB;6UJC;7Y1T,Integrin beta-8
P26012,0.108,-11.8,906.883,382,6DJP;6OM1;6OM2;6UJA;6UJB;6UJC;7Y1T,Integrin beta-8
P26012,0.741,-11.1,1413.021,551,6DJP;6OM1;6OM2;6UJA;6UJB;6UJC;7Y1T,Integrin beta-8
P26012,0.054,23.9,1425.645,104,6DJP;6OM1;6OM2;6UJA;6UJB;6UJC;7Y1T,Integrin beta-8
P42261,0.022,25.5,2751.61,618,6X5Q,"Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1)"
P42261,0.105,0.2,1162.375,672,6X5Q,"Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1)"
P42261,0.697,-5.3,861.797,422,6X5Q,"Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1)"
P42261,0.021,-13.8,3031.097,91,6X5Q,"Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1)"
P42261,0.141,-15.8,850.453,236,6X5Q,"Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1)"
P42262,0.105,25.8,1666.338,620,2WJW;2WJX;2XHD;3R7X;3RN8;3RNN;3UA8;5H8S;5YBF;5YBG;5ZG0;5ZG1;5ZG2;5ZG3;7F3O,"Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)"
P42262,0.027,60.6,2980.871,823,2WJW;2WJX;2XHD;3R7X;3RN8;3RNN;3UA8;5H8S;5YBF;5YBG;5ZG0;5ZG1;5ZG2;5ZG3;7F3O,"Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)"
P42262,0.135,-3.3,1505.056,679,2WJW;2WJX;2XHD;3R7X;3RN8;3RNN;3UA8;5H8S;5YBF;5YBG;5ZG0;5ZG1;5ZG2;5ZG3;7F3O,"Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)"
P42262,0.659,-1.3,949.297,422,2WJW;2WJX;2XHD;3R7X;3RN8;3RNN;3UA8;5H8S;5YBF;5YBG;5ZG0;5ZG1;5ZG2;5ZG3;7F3O,"Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)"
P42262,0.656,13.6,949.464,178,2WJW;2WJX;2XHD;3R7X;3RN8;3RNN;3UA8;5H8S;5YBF;5YBG;5ZG0;5ZG1;5ZG2;5ZG3;7F3O,"Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)"
P42262,0.642,1.3,1080.962,330,2WJW;2WJX;2XHD;3R7X;3RN8;3RNN;3UA8;5H8S;5YBF;5YBG;5ZG0;5ZG1;5ZG2;5ZG3;7F3O,"Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)"
P42263,0.065,27.8,3476.887,632,,
P42263,0.672,33.2,1474.211,548,,
P42263,0.684,-7.0,1519.915,686,,
P42263,0.554,0.2,579.904,87,,
P42263,0.612,-7.2,1243.091,174,,
P48058,0.58,0.2,564.452,80,,
P48058,0.596,-3.9,1335.214,183,,
P48058,0.039,64.2,4283.997,825,,
P48058,0.549,28.9,1666.721,623,,
Q9ULK0,0.574,161.9,7837.092,613,,
Q9ULK0,0.554,-7.7,1026.235,182,,
Q9ULK0,0.625,-3.0,1233.0,43,,
Q9ULK0,0.623,2.4,2003.586,105,,
O43424,0.134,-7.3,923.184,288,5KC8;5KCA,"Glutamate receptor ionotropic, delta-2 (GluD2) (GluR delta-2 subunit)"
O43424,0.109,9.4,928.688,79,5KC8;5KCA,"Glutamate receptor ionotropic, delta-2 (GluD2) (GluR delta-2 subunit)"
O43424,0.671,-22.6,3413.656,777,5KC8;5KCA,"Glutamate receptor ionotropic, delta-2 (GluD2) (GluR delta-2 subunit)"
O43424,0.746,-3.0,1456.956,198,5KC8;5KCA,"Glutamate receptor ionotropic, delta-2 (GluD2) (GluR delta-2 subunit)"
O43424,0.712,91.5,4476.335,837,5KC8;5KCA,"Glutamate receptor ionotropic, delta-2 (GluD2) (GluR delta-2 subunit)"
O43424,0.629,50.2,2236.277,637,5KC8;5KCA,"Glutamate receptor ionotropic, delta-2 (GluD2) (GluR delta-2 subunit)"
P39086,0.606,34.0,1288.807,666,2ZNS;2ZNT;2ZNU;3FUZ;3FV1;3FV2;3FVG;3FVK;3FVN;3FVO;4MF3,"Glutamate receptor ionotropic, kainate 1 (GluK1) (Excitatory amino acid receptor 3) (EAA3) (Glutamate receptor 5) (GluR-5) (GluR5)"
P39086,0.025,33.0,2884.728,654,2ZNS;2ZNT;2ZNU;3FUZ;3FV1;3FV2;3FVG;3FVK;3FVN;3FVO;4MF3,"Glutamate receptor ionotropic, kainate 1 (GluK1) (Excitatory amino acid receptor 3) (EAA3) (Glutamate receptor 5) (GluR-5) (GluR5)"
P39086,0.043,-21.8,5171.908,53,2ZNS;2ZNT;2ZNU;3FUZ;3FV1;3FV2;3FVG;3FVK;3FVN;3FVO;4MF3,"Glutamate receptor ionotropic, kainate 1 (GluK1) (Excitatory amino acid receptor 3) (EAA3) (Glutamate receptor 5) (GluR-5) (GluR5)"
Q13002,0.658,158.9,8055.536,616,3QXM;5CMM,"Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6)"
Q13002,0.674,-28.2,1789.218,439,3QXM;5CMM,"Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6)"
Q13002,0.102,-3.3,1264.317,693,3QXM;5CMM,"Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6)"
Q13002,0.545,14.8,976.485,315,3QXM;5CMM,"Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6)"
Q13002,0.104,-6.8,1022.209,52,3QXM;5CMM,"Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6)"
Q13002,0.159,12.8,1448.45,17,3QXM;5CMM,"Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6)"
Q13003,0.062,58.9,3968.405,835,,
Q13003,0.648,30.7,1770.878,653,,
Q13003,0.042,-13.6,1574.001,442,,
Q13003,0.605,-4.0,1122.813,192,,
Q13003,0.532,-0.1,1445.022,318,,
Q16099,0.749,-0.7,1135.253,37,,
Q16099,0.58,1.1,1783.035,179,,
Q16099,0.508,9.5,1181.86,413,,
Q16099,0.048,122.0,5044.124,815,,
Q16099,0.678,72.4,3240.275,621,,
Q16478,0.528,60.5,2601.512,823,,
Q16478,0.038,53.7,2496.658,620,,
Q16478,0.526,39.2,1282.099,538,,
Q16478,0.593,-1.4,2271.619,190,,
Q8TCU5,0.586,-7.5,2637.48,215,,
Q8TCU5,0.136,9.0,1282.948,465,,
Q8TCU5,0.604,-5.3,2112.822,150,,
Q8TCU5,0.579,6.8,768.105,401,,
Q8TCU5,0.577,-1.8,923.735,862,,
Q8TCU5,0.588,138.0,6406.007,724,,
Q8TCU5,0.025,-2.1,2643.611,1090,,
O60391,0.64,-11.3,1459.714,262,,
O60391,0.614,4.7,1825.224,119,,
O60391,0.049,-0.0,2799.845,997,,
O60391,0.542,-3.5,984.838,426,,
O60391,0.66,6.9,1097.15,762,,
O60391,0.629,109.2,6211.439,624,,
Q12879,0.602,-0.7,1182.227,83,3NFL;5H8F;5H8H;5H8N;5H8Q;5I2K;5I2N;5KCJ;5KDT;5TP9;5TPA;6IRA;6IRF;6IRG;6IRH;7EOQ;7EOR;7EOS;7EOT;7EOU;7EU7,"Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A) (hNR2A)"
Q12879,0.137,-10.2,1260.827,439,3NFL;5H8F;5H8H;5H8N;5H8Q;5I2K;5I2N;5KCJ;5KDT;5TP9;5TPA;6IRA;6IRF;6IRG;6IRH;7EOQ;7EOR;7EOS;7EOT;7EOU;7EU7,"Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A) (hNR2A)"
Q12879,0.519,9.8,1057.426,528,3NFL;5H8F;5H8H;5H8N;5H8Q;5I2K;5I2N;5KCJ;5KDT;5TP9;5TPA;6IRA;6IRF;6IRG;6IRH;7EOQ;7EOR;7EOS;7EOT;7EOU;7EU7,"Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A) (hNR2A)"
Q12879,0.105,3.5,1233.255,429,3NFL;5H8F;5H8H;5H8N;5H8Q;5I2K;5I2N;5KCJ;5KDT;5TP9;5TPA;6IRA;6IRF;6IRG;6IRH;7EOQ;7EOR;7EOS;7EOT;7EOU;7EU7,"Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A) (hNR2A)"
Q12879,0.565,154.3,7854.605,562,3NFL;5H8F;5H8H;5H8N;5H8Q;5I2K;5I2N;5KCJ;5KDT;5TP9;5TPA;6IRA;6IRF;6IRG;6IRH;7EOQ;7EOR;7EOS;7EOT;7EOU;7EU7,"Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A) (hNR2A)"
Q13224,0.668,-9.0,1858.081,115,5EWJ;5EWL;5EWM;7EU8;7KL0;7KL1;7KL2;7UIS;7UJP;7UJQ;7UJR;7UJS;7UJT,"Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3)"
Q13224,0.653,-2.3,742.069,331,5EWJ;5EWL;5EWM;7EU8;7KL0;7KL1;7KL2;7UIS;7UJP;7UJQ;7UJR;7UJS;7UJT,"Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3)"
Q13224,0.025,-12.6,1077.449,437,5EWJ;5EWL;5EWM;7EU8;7KL0;7KL1;7KL2;7UIS;7UJP;7UJQ;7UJR;7UJS;7UJT,"Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3)"
Q13224,0.514,5.6,824.676,527,5EWJ;5EWL;5EWM;7EU8;7KL0;7KL1;7KL2;7UIS;7UJP;7UJQ;7UJR;7UJS;7UJT,"Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3)"
Q13224,0.043,65.6,4065.452,828,5EWJ;5EWL;5EWM;7EU8;7KL0;7KL1;7KL2;7UIS;7UJP;7UJQ;7UJR;7UJS;7UJT,"Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3)"
Q13224,0.678,69.1,2526.184,570,5EWJ;5EWL;5EWM;7EU8;7KL0;7KL1;7KL2;7UIS;7UJP;7UJQ;7UJR;7UJS;7UJT,"Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3)"
Q14957,0.551,0.8,1064.806,111,,
Q14957,0.606,2.7,917.642,524,,
Q14957,0.108,32.4,1901.341,547,,
Q14957,0.227,22.0,1925.524,835,,
Q14957,0.572,10.4,1217.319,897,,
Q14957,0.089,35.2,1734.841,625,,
O15399,0.546,3.5,923.614,89,,
O15399,0.582,-4.5,1347.388,133,,
O15399,0.11,30.5,1753.547,577,,
O15399,0.199,19.9,2398.896,864,,
O15399,0.661,39.8,1375.88,601,,
Q05586,0.687,-1.4,2775.915,109,2HQW;2NR1;3BYA;5H8F;5H8H;5H8N;5H8Q;5I2K;5I2N;5KCJ;5KDT;5TP9;5TPA;6IRA;6IRF;6IRG;6IRH;7EOQ;7EOR;7EOS;7EOT;7EOU;7EU7;7EU8,"Glutamate receptor ionotropic, NMDA 1 (GluN1) (Glutamate [NMDA] receptor subunit zeta-1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1)"
Q05586,0.68,-19.9,1887.544,757,2HQW;2NR1;3BYA;5H8F;5H8H;5H8N;5H8Q;5I2K;5I2N;5KCJ;5KDT;5TP9;5TPA;6IRA;6IRF;6IRG;6IRH;7EOQ;7EOR;7EOS;7EOT;7EOU;7EU7;7EU8,"Glutamate receptor ionotropic, NMDA 1 (GluN1) (Glutamate [NMDA] receptor subunit zeta-1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1)"
Q05586,0.689,130.6,9413.549,608,2HQW;2NR1;3BYA;5H8F;5H8H;5H8N;5H8Q;5I2K;5I2N;5KCJ;5KDT;5TP9;5TPA;6IRA;6IRF;6IRG;6IRH;7EOQ;7EOR;7EOS;7EOT;7EOU;7EU7;7EU8,"Glutamate receptor ionotropic, NMDA 1 (GluN1) (Glutamate [NMDA] receptor subunit zeta-1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1)"
P30988,0.67,6.6,1426.383,402,5II0;5UZ7;6NIY;6PFO;6PGQ;7TYF;7TYH;7TYI;7TYL;7TYN;7TYO;7TYW;7TYX;7TYY;7TZF,Calcitonin receptor (CT-R)
P30988,0.067,83.8,5823.055,308,5II0;5UZ7;6NIY;6PFO;6PGQ;7TYF;7TYH;7TYI;7TYL;7TYN;7TYO;7TYW;7TYX;7TYY;7TZF,Calcitonin receptor (CT-R)
Q16602,0.669,4.0,1695.196,395,3AQF;3N7P;3N7R;3N7S;4RWF;4RWG;5V6Y;6D1U;6E3Y;6UMG;6UUN;6UUS;6UVA;6V2E;6ZHO;6ZIS;7KNT;7KNU;7P0F;7P0I,Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor)
Q16602,0.101,35.2,2676.767,238,3AQF;3N7P;3N7R;3N7S;4RWF;4RWG;5V6Y;6D1U;6E3Y;6UMG;6UUN;6UUS;6UVA;6V2E;6ZHO;6ZIS;7KNT;7KNU;7P0F;7P0I,Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor)
Q16602,0.077,13.9,988.73,142,3AQF;3N7P;3N7R;3N7S;4RWF;4RWG;5V6Y;6D1U;6E3Y;6UMG;6UUN;6UUS;6UVA;6V2E;6ZHO;6ZIS;7KNT;7KNU;7P0F;7P0I,Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor)
P34998,0.126,79.4,6849.421,236,2L27;3EHS;3EHT;3EHU;4K5Y;4Z9G;6P9X;6PB0,Corticotropin-releasing factor receptor 1 (CRF-R-1) (CRF-R1) (CRFR-1) (Corticotropin-releasing hormone receptor 1) (CRH-R-1) (CRH-R1)
Q13324,0.505,6.0,1397.263,370,3N93;3N95;3N96;6PB1;7TRY;7TS0,Corticotropin-releasing factor receptor 2 (CRF-R-2) (CRF-R2) (CRFR-2) (Corticotropin-releasing hormone receptor 2) (CRH-R-2) (CRH-R2)
Q13324,0.086,37.4,2560.774,207,3N93;3N95;3N96;6PB1;7TRY;7TS0,Corticotropin-releasing factor receptor 2 (CRF-R-2) (CRF-R2) (CRFR-2) (Corticotropin-releasing hormone receptor 2) (CRH-R-2) (CRH-R2)
Q13324,0.591,16.1,1080.523,267,3N93;3N95;3N96;6PB1;7TRY;7TS0,Corticotropin-releasing factor receptor 2 (CRF-R-2) (CRF-R2) (CRFR-2) (Corticotropin-releasing hormone receptor 2) (CRH-R-2) (CRH-R2)
Q02643,0.179,152.9,8013.785,171,2XDG;7CZ5,Growth hormone-releasing hormone receptor (GHRH receptor) (Growth hormone-releasing factor receptor) (GRF receptor) (GRFR)
Q02643,0.478,31.0,1198.737,82,2XDG;7CZ5,Growth hormone-releasing hormone receptor (GHRH receptor) (Growth hormone-releasing factor receptor) (GRF receptor) (GRFR)
P48546,0.199,163.5,10148.121,179,2QKH;4HJ0;6DKJ;7DTY;7FIN;7FIY;7RA3;7RBT;7VAB,Gastric inhibitory polypeptide receptor (GIP-R) (Glucose-dependent insulinotropic polypeptide receptor)
P43220,0.036,16.7,936.507,253,3C59;3C5T;3IOL;4ZGM;5E94;5NX2;5OTT;5OTU;5OTV;5OTW;5OTX;5VEW;5VEX;6B3J;6GB1;6ORV;6VCB;6X18;6X19;6X1A;6XOX;7C2E;7DUQ;7DUR;7E14;7EVM;7FIM;7KI0;7KI1;7LCI;7LCJ;7LCK;7LLL;7LLY;7RG9;7RGP;7RTB;7S15;7S1M;7S3I;7VBH;7VBI;7X8R;7X8S,Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R)
P43220,0.659,46.0,4140.598,188,3C59;3C5T;3IOL;4ZGM;5E94;5NX2;5OTT;5OTU;5OTV;5OTW;5OTX;5VEW;5VEX;6B3J;6GB1;6ORV;6VCB;6X18;6X19;6X1A;6XOX;7C2E;7DUQ;7DUR;7E14;7EVM;7FIM;7KI0;7KI1;7LCI;7LCJ;7LCK;7LLL;7LLY;7RG9;7RGP;7RTB;7S15;7S1M;7S3I;7VBH;7VBI;7X8R;7X8S,Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R)
P43220,0.631,16.2,1016.106,349,3C59;3C5T;3IOL;4ZGM;5E94;5NX2;5OTT;5OTU;5OTV;5OTW;5OTX;5VEW;5VEX;6B3J;6GB1;6ORV;6VCB;6X18;6X19;6X1A;6XOX;7C2E;7DUQ;7DUR;7E14;7EVM;7FIM;7KI0;7KI1;7LCI;7LCJ;7LCK;7LLL;7LLY;7RG9;7RGP;7RTB;7S15;7S1M;7S3I;7VBH;7VBI;7X8R;7X8S,Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R)
O95838,0.668,45.9,3867.266,350,7D68,Glucagon-like peptide 2 receptor (GLP-2 receptor) (GLP-2-R) (GLP-2R)
O95838,0.033,18.8,739.974,262,7D68,Glucagon-like peptide 2 receptor (GLP-2 receptor) (GLP-2-R) (GLP-2R)
Q5UAW9,0.047,44.7,1817.171,51,,
P41586,0.202,151.7,9042.179,195,2JOD;3N94;6LPB;6M1H;6M1I;6P9Y;7JQD,Pituitary adenylate cyclase-activating polypeptide type I receptor (PACAP type I receptor) (PACAP-R-1) (PACAP-R1)
Q03431,0.204,154.6,9895.846,229,1BL1;3C4M;3H3G;3L2J;4Z8J;5EMB;6NBF;6NBH;6NBI;7UZP;7VVJ;7VVK;7VVL;7VVM;7VVN;7VVO,Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor)
P49190,0.201,147.0,9943.268,252,7F16,Parathyroid hormone 2 receptor (PTH2 receptor)
P49190,0.643,3.6,1868.414,70,7F16,Parathyroid hormone 2 receptor (PTH2 receptor)
P47872,0.159,190.3,8285.988,184,6WI9;6WZG;7D3S,Secretin receptor (SCT-R)
P47872,0.615,21.0,808.645,92,6WI9;6WZG;7D3S,Secretin receptor (SCT-R)
P32241,0.233,202.5,8778.556,184,1OF2;1OGT;3B3I;3B6S;3DTX;3HCV;5DEF;5DEG;5IB1;5IB2;5IB3;5IB4;5IB5;6VN7;7ALO,Vasoactive intestinal polypeptide receptor 1 (VIP-R-1) (Pituitary adenylate cyclase-activating polypeptide type II receptor) (PACAP type II receptor) (PACAP-R-2) (PACAP-R2) (VPAC1)
P41587,0.573,20.9,1519.904,147,2X57;7VQX;7WBJ,Vasoactive intestinal polypeptide receptor 2 (VIP-R-2) (Helodermin-preferring VIP receptor) (Pituitary adenylate cyclase-activating polypeptide type III receptor) (PACAP type III receptor) (PACAP-R-3) (PACAP-R3) (VPAC2)
P41587,0.041,28.0,1623.868,228,2X57;7VQX;7WBJ,Vasoactive intestinal polypeptide receptor 2 (VIP-R-2) (Helodermin-preferring VIP receptor) (Pituitary adenylate cyclase-activating polypeptide type III receptor) (PACAP type III receptor) (PACAP-R-3) (PACAP-R3) (VPAC2)
